Blood Test Reference

What it isGlucose is the sugar your body uses as primary fuel. Most of it comes from dietary carbohydrates, and the liver also synthesizes it on demand. After an overnight fast, the level reflects how well your liver, pancreas, and muscle tissue coordinate fuel handling without any incoming meal.

DoesGlucose powers nearly every cell and is the obligate fuel for the brain. Insulin and glucagon push it into and out of storage to keep blood levels in a tight band.

GoodStable fasting glucose signals intact insulin sensitivity and healthy metabolic flexibility — the foundation under longevity, body composition, and cognitive performance.

BadMildly elevated fasting glucose is the earliest commonly-tested fingerprint of insulin resistance and predicts type 2 diabetes, fatty liver, dementia, and cardiovascular events years out. Persistently high glucose glycates tissues, damages the endothelium, and accelerates every chronic disease of aging.

What it isA1c is the percentage of hemoglobin molecules inside red blood cells that have sugar permanently bonded to them. Because red blood cells live about 120 days, A1c reflects the average ambient glucose load over roughly the previous three months.

DoesIt acts as a time-integrated record of blood sugar — not a snapshot. Every glucose excursion leaves a mark, and that mark only clears as old red cells get replaced.

GoodLow A1c indicates stable, low-amplitude glucose handling and predicts a long disease-free runway across cardiovascular, cognitive, and metabolic domains.

BadHigh A1c indicates chronic hyperglycemia and tracks tightly with diabetes, cardiovascular events, dementia, retinopathy, neuropathy, and accelerated aging. Even in the "normal" range, climbing A1c carries excess risk.

What it isInsulin is the hormone the pancreas releases to push glucose into cells and shut down liver glucose output. Fasting insulin measures how much your pancreas is secreting at rest, when no food has arrived for at least 10–12 hours.

DoesDrives glucose uptake into muscle, fat, and liver; switches off fat burning; promotes growth and storage; regulates sodium retention.

GoodLow fasting insulin signals high insulin sensitivity — the metabolic substrate of lean physiology, durable energy, and a long healthspan.

BadHigh fasting insulin is the earliest fingerprint of insulin resistance, rising years before glucose or A1c move. Sustained hyperinsulinemia drives visceral fat, fatty liver, hypertension, cancer growth signals, polycystic ovaries, and brain atrophy.

What it isHOMA-IR is a calculated index — fasting glucose multiplied by fasting insulin, divided by 405 — that combines two numbers into a single estimate of insulin resistance. It captures the relationship between the demand (glucose) and the effort required to control it (insulin).

DoesQuantifies how hard the pancreas is working to keep blood sugar normal at rest.

GoodA low score means cells respond crisply to small amounts of insulin — the metabolic signature of lean, fit physiology.

BadA high score reflects insulin resistance: cells ignore the signal, the pancreas pushes harder, and the body slides toward fatty liver, type 2 diabetes, hypertension, and accelerated aging.

What it isWhen the pancreas makes insulin, it cleaves a precursor protein and releases insulin plus a "connecting peptide" in a one-to-one ratio. C-peptide is cleared slowly by the kidneys, giving a more stable readout of native pancreatic insulin output than insulin itself.

DoesActs as a fingerprint of the pancreas's actual insulin production, unaffected by injected insulin.

GoodMid-low C-peptide in someone with normal glucose suggests the pancreas isn't being driven hard — a hallmark of insulin sensitivity.

BadHigh C-peptide signals hyperinsulinemia and pancreatic strain, predicting diabetes, fatty liver, and cardiovascular disease. Very low C-peptide in a diabetic indicates type 1 / beta-cell failure.

What it isA standardized challenge test — drink 75 grams of pure glucose dissolved in water, then measure blood sugar two hours later. The body's response shows how efficiently it absorbs, signals, and clears a large fuel bolus.

DoesStress-tests the glucose-insulin axis the way a treadmill stress-tests the heart.

GoodA clean two-hour return to baseline signals robust insulin sensitivity and a wide metabolic reserve.

BadA delayed or excessive post-load glucose reveals insulin resistance and prediabetes that fasting glucose misses entirely. Sustained post-load hyperglycemia drives cardiovascular events and beta-cell burnout.

What it isWhen blood glucose binds to circulating proteins (mostly albumin), it forms fructosamine. Because those proteins turn over every two to three weeks, fructosamine captures a shorter glycemic window than A1c.

DoesActs as a short-window mirror of average blood sugar.

GoodLow fructosamine confirms stable, low-amplitude glucose handling in the recent weeks.

BadElevation flags recent hyperglycemia and is especially valuable when A1c can't be trusted — pregnancy, hemolytic anemia, hemoglobin variants, blood transfusions.

What it isA simple back-translation of A1c into a single average glucose number using a fixed equation. The body doesn't measure it directly — the lab calculates it from A1c.

DoesRestates the same A1c information in the same units a continuous glucose monitor would show.

GoodA low eAG mirrors a low A1c — stable, low-amplitude glucose handling and long-term metabolic health.

BadHigh eAG, like high A1c, predicts cardiovascular disease, dementia, retinopathy, neuropathy, and accelerated aging.

What it isA calculated discrepancy between the A1c the body actually shows and the A1c predicted from a fructosamine measurement. The gap exposes hidden quirks in how an individual glycates proteins or how long their red cells live.

DoesQuality-checks A1c by comparing it against a different glycation marker.

GoodA near-zero gap means A1c can be trusted as an honest mirror of average glucose.

BadA large positive gap suggests A1c is overstating true glucose exposure (long-lived red cells, faster glycation); a large negative gap suggests it understates (short-lived cells, hemoglobinopathy). Both signal that you need a backup marker before making decisions.

What it isLeptin is a hormone manufactured and released by fat cells in proportion to total body fat mass. It travels to the hypothalamus where it signals "enough fuel on board."

DoesRegulates appetite, energy expenditure, thyroid output, and reproductive hormone production. The brain reads leptin as a long-term fat-stores gauge.

GoodLow-to-moderate leptin in a lean person reflects appropriate fat mass and a brain that's hearing the signal cleanly.

BadChronically high leptin causes leptin resistance — the brain stops listening, appetite stays elevated, and the metabolic state of obesity locks in. High leptin tracks visceral fat, insulin resistance, and cardiovascular risk.

What it isAdiponectin is a hormone secreted by fat cells, but unusually it goes up as fat mass goes down — especially as visceral fat shrinks. It travels to muscle, liver, and the vasculature.

DoesPromotes insulin sensitivity, fat oxidation, anti-inflammatory tone, and endothelial repair.

GoodHigh adiponectin correlates with lean body composition, low cardiovascular risk, and longevity.

BadLow adiponectin tracks visceral obesity, fatty liver, insulin resistance, atherosclerosis, and type 2 diabetes. It tends to fall as belly fat rises and stays low until visceral fat is meaningfully reduced.

What it isA calculated index combining fasting triglycerides and fasting glucose into a single number. Because it doesn't require an insulin assay, it's available from any standard panel.

DoesEstimates insulin resistance using two cheap, ubiquitous markers.

GoodA low TyG score signals strong insulin sensitivity — clean carbohydrate handling without an excess triglyceride load.

BadA high TyG score predicts diabetes, fatty liver, heart attack, stroke, and all-cause mortality. It often flags risk before A1c moves.

What it isUric acid is the end product of purine metabolism — purines coming from DNA in food, dietary fructose, alcohol, and cellular turnover. The kidneys clear most of it; the gut handles the rest.

DoesFunctions as a circulating antioxidant in small amounts but crystallizes in joints and tissues when concentrations climb too high.

GoodA mid-low level provides antioxidant benefit without crystallization risk.

BadHigh uric acid causes gout, kidney stones, and chronic kidney disease, and independently predicts hypertension, insulin resistance, fatty liver, and cardiovascular events. Fructose is its single largest dietary driver.

What it isAmylase is a digestive enzyme produced by the pancreas and salivary glands that breaks down starches into smaller sugars.

DoesInitiates carbohydrate digestion in the mouth and continues in the small intestine.

GoodA mid-range amylase signals normal pancreatic and salivary.

BadSharp elevation flags acute pancreatitis or pancreatic duct injury. Low amylase can suggest chronic pancreatic insufficiency.

What it isLipase is a pancreatic digestive enzyme that breaks down dietary fats into fatty acids and glycerol for absorption.

DoesDrives fat digestion in the small intestine.

GoodA mid-range lipase signals normal pancreatic exocrine.

BadSharp elevation specifically flags acute pancreatitis with more accuracy than amylase. Low lipase can indicate chronic pancreatic insufficiency.

What it isIGF-1 is a peptide hormone produced primarily by the liver in response to growth hormone signaling. It carries out most of growth hormone's downstream effects on tissue growth.

DoesDrives muscle protein synthesis, bone growth, neurogenesis, and tissue repair; also drives cell proliferation more broadly.

GoodMid-range IGF-1 supports muscle, bone, and tissue repair without excess growth signaling.

BadBoth low and high IGF-1 track mortality. Low IGF-1 signals frailty, poor recovery, and increased cardiovascular risk. High IGF-1 drives accelerated aging and cancer risk; very high suggests acromegaly.

What it isThe dominant carrier protein for IGF-1 in circulation, regulating how much IGF-1 is free to act on tissues.

DoesBuffers IGF-1 availability and extends its half-life.

GoodA mid-range IGFBP-3 with appropriate IGF-1 signals balanced growth hormone axis.

BadPatterns of IGFBP-3 versus IGF-1 help clinicians evaluate growth hormone disorders.

What it isGlucagon is a hormone produced by pancreatic alpha cells that opposes insulin — it raises blood sugar by signaling the liver to release stored glucose and make new glucose.

DoesMaintains blood glucose during fasting and exercise.

GoodA mid-range glucagon signals balanced fuel-sensing physiology.

BadInappropriately high glucagon contributes to hyperglycemia in type 2 diabetes. Very high glucagon suggests rare glucagonoma.

What it isTotal cholesterol is the sum of cholesterol carried in every type of lipoprotein particle — LDL, HDL, VLDL, and remnants. The liver makes most cholesterol; diet contributes a smaller fraction.

DoesCholesterol is a structural component of every cell membrane and the precursor to bile acids, steroid hormones, and vitamin D. It rides in lipoproteins because it's fat-insoluble.

GoodA moderate level reflects healthy production and clearance, with enough raw material for membranes and hormones.

BadAs a standalone number, total cholesterol is a crude predictor — what matters is which particles carry it. Two people with identical total cholesterol can have wildly different cardiovascular risk.

What it isLDL-C measures the cholesterol cargo carried inside low-density lipoprotein particles. Most labs calculate it from total cholesterol, HDL, and triglycerides; some measure it directly.

DoesLDL particles transport cholesterol from the liver to peripheral tissues. The particles themselves — not the cholesterol they carry — drive atherosclerosis by depositing in arterial walls.

GoodLow LDL-C reduces the substrate available to deposit in vessel walls and is associated with longevity-grade cardiovascular health.

BadElevated LDL-C drives atherosclerosis, heart attack, and stroke. The causal relationship is dose- and time-dependent: lower for longer is better.

What it isHDL particles are small, dense lipoproteins that scavenge excess cholesterol from peripheral tissues and ferry it back to the liver for disposal. HDL-C measures the cholesterol cargo they carry.

DoesReverse cholesterol transport; anti-inflammatory and antioxidant activity in the vessel wall.

GoodMid-to-high HDL signals a working reverse-transport system and tracks lower cardiovascular event rates.

BadVery low HDL flags metabolic syndrome and elevated cardiovascular risk. Counterintuitively, very high HDL (above ~90 mg/dL) is no longer considered uniformly protective and may track dysfunctional particles.

What it isTriglycerides are the storage form of fat — three fatty acids glued to a glycerol backbone. The liver makes them from excess carbohydrate; the gut packages dietary fat into them. They ride in VLDL, chylomicrons, and LDL.

DoesDeliver fatty acids to muscle for fuel and to adipose tissue for storage.

GoodLow fasting triglycerides indicate efficient fuel use, insulin sensitivity, and a low-remnant atherogenic profile.

BadHigh triglycerides are a direct readout of carbohydrate overload, insulin resistance, and fatty liver. Sustained elevation drives atherogenic dyslipidemia, pancreatitis, and cardiovascular disease.

What it isA simple subtraction — total cholesterol minus HDL — that captures the cholesterol carried in every atherogenic particle (LDL, VLDL, IDL, Lp(a), chylomicron remnants) in one number.

DoesSums up the cholesterol available to deposit into vessel walls.

GoodLow non-HDL indicates a low burden of atherogenic particles and tracks lower cardiovascular event rates.

BadElevated non-HDL predicts heart attack and stroke better than LDL-C alone, especially in people with high triglycerides where LDL-C is unreliable.

What it isApoB is the structural protein on the surface of every atherogenic lipoprotein particle — one ApoB molecule per particle. Measuring ApoB therefore gives a direct count of atherogenic particles.

DoesEach ApoB-containing particle is a candidate to deposit cholesterol into the artery wall. The count of these particles, not the cholesterol they carry, drives atherosclerosis.

GoodLow ApoB means few atherogenic particles in circulation and is the single strongest lipid predictor of low cardiovascular risk.

BadElevated ApoB causally drives atherosclerosis, heart attack, and stroke — even when LDL-C looks reassuring (a common discordance in metabolic syndrome).

What it isApoA1 is the principal structural protein of HDL particles. Counting ApoA1 effectively counts HDL particles and reflects the capacity of the reverse cholesterol transport system.

DoesForms HDL, accepts cholesterol efflux from cells, and triggers the enzyme that matures HDL particles.

GoodHigh ApoA1 indicates a robust reverse-transport system and tracks lower cardiovascular event rates. The ApoB/ApoA1 ratio is a stronger predictor than either alone.

BadLow ApoA1 signals impaired cholesterol clearance and metabolic syndrome.

What it isLp(a) is an LDL-like particle with an additional "apolipoprotein(a)" tail attached. Its concentration is roughly 90% genetically determined and remains stable across a lifetime once set in early childhood.

DoesFunctions as an unusually atherogenic and pro-thrombotic particle — it deposits cholesterol in artery walls and promotes clotting at the same time.

GoodLow Lp(a) removes a major independent cardiovascular risk factor and the benefit is essentially "luck of the draw" inheritance.

BadElevated Lp(a) drives premature heart attack, stroke, and aortic stenosis independent of LDL. About 20% of the population inherits high levels.

What it isA direct count of LDL particles measured by nuclear magnetic resonance spectroscopy. Conceptually parallel to ApoB — both count atherogenic particles, just by different methods.

DoesQuantifies the supply of LDL particles available to deposit cholesterol into vessel walls.

GoodLow LDL-P means few particles knocking on the endothelium and predicts low cardiovascular risk regardless of how much cholesterol each particle carries.

BadElevated LDL-P drives atherosclerosis. When LDL-C and LDL-P disagree, the higher of the two carries the risk — common in insulin resistance.

What it isA measurement of the average diameter of LDL particles. The particles come in a spectrum from large and buoyant to small and dense.

DoesSmall dense LDL penetrates the artery wall more readily and oxidizes more quickly than large buoyant LDL, so size shifts the per-particle atherogenicity.

GoodLarge buoyant LDL (Pattern A) is the less harmful phenotype — fewer particles slip into the subendothelial space.

BadSmall dense LDL (Pattern B) is the metabolic-syndrome phenotype — high triglycerides, low HDL, insulin resistance — and carries elevated cardiovascular risk per particle.

What it isA direct count of HDL particles in circulation, measured by NMR spectroscopy. Reflects the capacity of the reverse cholesterol transport system more accurately than HDL-C alone.

DoesEach HDL particle is a workhorse — pulling cholesterol from peripheral tissues and ferrying it back to the liver.

GoodA higher particle count tracks better reverse transport and lower cardiovascular event rates.

BadLow HDL-P signals impaired clearance and metabolic syndrome and predicts cardiovascular risk even when HDL-C looks acceptable.

What it isThe average diameter of HDL particles, measured by NMR.

DoesLarger, more mature HDL particles are generally more functional for reverse cholesterol transport, though the relationship is not perfectly linear.

GoodMid-large HDL size tends to track functional particles and better cardiovascular outcomes.

BadVery small HDL particles can signal impaired maturation; abnormally large HDL particles have been associated with dysfunction in some contexts. Size alone is a softer predictor than particle number.

What it isVLDL particles are made by the liver to ship triglycerides into the bloodstream. They carry a smaller cholesterol cargo and a heavy triglyceride load.

DoesDeliver triglycerides to peripheral tissues; their leftover "remnant" particles after delivery are atherogenic.

GoodLow VLDL signals efficient lipid handling and minimal remnant particle burden.

BadElevated VLDL marks insulin resistance, fatty liver, and the atherogenic dyslipidemia of metabolic syndrome. Remnants directly deposit in vessel walls.

What it isA simple ratio — total cholesterol divided by HDL — that compares the atherogenic burden against the protective fraction in a single number.

DoesEstimates the balance between cholesterol going into vessel walls and cholesterol being carried back to the liver.

GoodA low ratio means the protective fraction is large relative to the total and tracks lower cardiovascular event rates.

BadA high ratio captures the dyslipidemia of metabolic syndrome and predicts heart attack and stroke.

What it isTriglycerides divided by HDL — a back-of-the-envelope ratio that doubles as a strong proxy for insulin resistance and small dense LDL.

DoesCaptures the metabolic-syndrome lipid pattern in one number.

GoodA low ratio signals insulin sensitivity, large buoyant LDL, and low cardiovascular risk.

BadA high ratio reflects insulin resistance, fatty liver, small dense LDL, and elevated cardiovascular risk — often before glucose or A1c move.

What it isA calculated log ratio of triglycerides to HDL cholesterol that compresses small dense LDL prediction into a single number without requiring particle-size testing.

DoesEstimates the atherogenic burden of the lipid profile by leveraging the strong correlation between elevated TG/HDL and small dense LDL.

GoodA low AIP signals a lipid profile dominated by large buoyant LDL and low cardiovascular risk.

BadA high AIP captures the atherogenic dyslipidemia of metabolic syndrome — small dense LDL, low HDL, elevated remnants.

What it isA simple calculated ratio of non-HDL cholesterol to HDL cholesterol — atherogenic burden over protective fraction.

DoesRestates the relationship between bad and good cholesterol carriers.

GoodA low coefficient indicates a favorable lipid balance.

BadA high coefficient captures the same dyslipidemia signal as TC/HDL ratio.

What it isA subset of LDL particles whose lipid and protein components have been chemically oxidized by reactive species. Once oxidized, LDL becomes a potent inflammatory trigger.

DoesOxidized LDL is taken up by macrophages in the vessel wall to form foam cells — the cellular kernel of atherosclerotic plaque.

GoodLow oxLDL suggests low oxidative burden and minimal active atherogenesis.

BadElevated oxLDL signals active plaque biology and predicts cardiovascular events independently of LDL-C.

What it isA panel of plant sterols (absorbed from the diet) and cholesterol precursors (made in the body) that reveal whether a person's cholesterol comes mostly from absorption or from de novo synthesis.

DoesFingerprints the dominant source of circulating cholesterol — gut absorption versus liver production.

GoodA balanced profile suggests neither pathway is dramatically overactive.

BadHigh plant sterol fractions identify "absorbers" who respond better to cholesterol-absorption blockers; high lathosterol identifies "synthesizers" who respond better to statins. Mismatched treatment underperforms.

What it isThe percentage of EPA plus DHA in red blood cell membranes, which reflects long-term dietary intake of marine omega-3 fatty acids and their integration into tissue.

DoesMembrane omega-3 content modulates inflammation, platelet, vascular tone, and neuronal signaling.

GoodA high index reflects a diet rich in fatty fish or omega-3 supplements and tracks lower cardiovascular mortality and slower cognitive decline.

BadA low index — common on a Western diet — predicts cardiovascular death, dementia, and depression.

What it isA ratio of two long-chain fatty acids in cell membranes — arachidonic acid (pro-inflammatory mediators) over EPA (anti-inflammatory mediators).

DoesCaptures the inflammatory tone built into the membrane lipid pool. Cell signals downstream of membrane phospholipids depend on this balance.

GoodA low ratio shifts membrane signaling toward anti-inflammatory mediators and tracks lower cardiovascular and inflammatory disease risk.

BadA high ratio drives pro-inflammatory signaling and increases cardiovascular events.

What it isThe ratio of total omega-6 fatty acids to omega-3 fatty acids in plasma or membranes.

DoesReflects the inflammatory tone written into the body's fatty acid pool. Excess omega-6 fuels pro-inflammatory eicosanoid production.

GoodA low ratio shifts the balance toward anti-inflammatory signaling and is associated with lower cardiovascular and metabolic disease.

BadA high ratio — the Western default — drives chronic inflammation, insulin resistance, and cardiovascular events.

What it isA high-sensitivity assay of C-reactive protein, an acute-phase protein made by the liver in response to systemic inflammation signals (chiefly IL-6). It detects the small fluctuations relevant to chronic disease that standard CRP misses.

DoesActs as a downstream readout of body-wide inflammatory tone.

GoodVery low hsCRP signals quiescent systemic inflammation — a hallmark of long-term cardiovascular and metabolic health.

BadPersistently elevated hsCRP predicts heart attack, stroke, type 2 diabetes, cognitive decline, depression, and many cancers. It's a transdiagnostic risk marker.

What it isHomocysteine is a sulfur-containing amino acid produced as a byproduct of methionine metabolism. It's recycled back to methionine (using folate and B12) or shunted to cysteine (using B6).

DoesReflects how efficiently the methylation cycle is running. When methylation enzymes lack their cofactors, homocysteine accumulates.

GoodLow homocysteine indicates fluent methylation and adequate B vitamin status.

BadElevated homocysteine damages the endothelium, drives oxidative stress, and predicts cardiovascular events, stroke, and brain atrophy with dementia.

What it isFibrinogen is a soluble plasma protein made by the liver that is converted to fibrin during clot formation. It also functions as an acute-phase reactant that rises with inflammation.

DoesForms the structural scaffold of blood clots; contributes to blood viscosity.

GoodA mid-range level provides adequate clotting capacity without thrombotic excess.

BadHigh fibrinogen increases blood viscosity and clot risk, predicting heart attack, stroke, and venous thromboembolism. It also reflects chronic systemic inflammation.

What it isMPO is an enzyme released by activated neutrophils and macrophages, including those infiltrating vulnerable arterial plaque. It produces reactive oxidants that damage the vessel wall.

DoesOxidizes LDL, consumes nitric oxide, and degrades the protective fibrous cap covering atherosclerotic plaque.

GoodLow MPO indicates quiescent vascular inflammation and stable plaque biology.

BadElevated MPO signals active plaque inflammation and instability, predicting near-term cardiac events independently of LDL or hsCRP.

What it isLp-PLA2 is an enzyme bound predominantly to LDL particles. It hydrolyzes oxidized phospholipids and generates pro-inflammatory mediators inside arterial plaque.

DoesDrives vessel-wall inflammation specifically, distinguishing arterial inflammation from systemic.

GoodLow Lp-PLA2 indicates a low-inflammation plaque environment.

BadElevated Lp-PLA2 predicts cardiovascular events, especially ischemic stroke, and tracks arterial inflammation more specifically than hsCRP.

What it isAn endogenously produced amino acid analog that competitively inhibits nitric oxide synthase, the enzyme that makes the body's most important vasodilator.

DoesBlocks nitric oxide production, stiffening blood vessels and impairing endothelial.

GoodLow ADMA preserves nitric oxide signaling, vasodilation, and a flexible endothelium.

BadElevated ADMA causes endothelial dysfunction — the earliest stage of atherosclerosis — and predicts cardiovascular events and mortality.

What it isA structural isomer of ADMA released during protein turnover. Unlike ADMA, it doesn't directly inhibit nitric oxide synthase, and the kidneys clear it almost entirely.

DoesActs as a sensitive marker of kidney filtration and, indirectly, endothelial health.

GoodLow SDMA tracks intact kidney and undamaged endothelium.

BadElevated SDMA signals early kidney dysfunction and predicts cardiovascular mortality.

What it isTMAO is produced when gut bacteria metabolize dietary choline, carnitine, and lecithin into trimethylamine, which the liver then oxidizes to TMAO. The microbiome composition determines how much gets made.

DoesPromotes cholesterol deposition in vessel walls, impairs reverse cholesterol transport, and increases platelet reactivity.

GoodLow TMAO signals a microbiome that doesn't aggressively convert dietary substrates and tracks lower cardiovascular risk.

BadElevated TMAO predicts heart attack, stroke, heart failure, and all-cause mortality independently of traditional risk factors.

What it isA fragment released when ventricular heart muscle is stretched or pressure-loaded. The heart cleaves a precursor protein into the active hormone (BNP) and this stable, easily-measured fragment (NT-proBNP).

DoesSignals the kidneys to excrete sodium and water and dilates blood vessels — the heart's own way of unloading pressure.

GoodLow NT-proBNP confirms an unstressed heart and intact diastolic and systolic.

BadElevated NT-proBNP signals heart failure, volume overload, or chronic cardiac stress, and predicts cardiovascular events and mortality.

What it isA protein anchored inside cardiac muscle cells that leaks into the bloodstream when those cells are injured. High-sensitivity assays detect it at exquisitely low levels.

DoesActs as a direct readout of cardiac muscle damage, from acute heart attack down to subclinical myocyte stress.

GoodBelow the detection limit confirms an uninjured myocardium and predicts the lowest cardiovascular event rates.

BadChronic low-grade elevation predicts future heart attack, heart failure, and mortality even in people without symptoms. Acute spikes diagnose myocardial infarction.

What it isA measurement of how fast red blood cells settle in a vertical tube over one hour. Inflammatory proteins make cells clump together and fall faster.

DoesProvides a non-specific window on systemic inflammation that responds more slowly than CRP.

GoodA low ESR signals quiescent systemic inflammation.

BadElevated ESR flags chronic inflammatory disease, autoimmune disorders, infection, or rarely malignancy. Very high ESR is a giant-cell arteritis red flag.

What it isC-reactive protein is produced by the liver in response to inflammatory cytokines, particularly IL-6. The standard assay detects the higher concentrations seen in acute infection or active inflammation.

DoesTags pathogens and damaged cells for clearance and amplifies inflammation.

GoodLow CRP signals quiescent systemic inflammation and intact baseline tone.

BadSharp elevation signals acute infection, severe inflammation, or autoimmune flare. Use hsCRP for subtle chronic inflammation that standard CRP misses.

What it isA ratio of CRP to albumin — inflammation against nutritional and synthetic capacity.

DoesCaptures the catabolic state seen in chronic illness where inflammation rises and albumin falls.

GoodA low ratio signals quiescent inflammation and intact nutrition.

BadA high ratio predicts mortality across cancer, sepsis, heart failure, and chronic kidney disease — often better than either component alone.

What it isA ratio capturing the relationship between systemic inflammation (CRP) and adaptive immune competence (lymphocytes).

DoesHighlights cases where chronic inflammation is exhausting adaptive immunity.

GoodA low ratio signals balanced immune-inflammatory tone.

BadA high ratio predicts cancer prognosis and worse outcomes in sepsis.

What it isA ratio that helps disentangle true iron status from inflammation-driven distortion of ferritin (which is itself an acute-phase reactant).

DoesCuts through the inflammation noise to clarify what ferritin is actually telling you.

GoodA balanced ratio with normal-range ferritin and low CRP signals true iron stores.

BadA high ferritin with high CRP suggests inflammation, not iron overload. A low ferritin with high CRP can indicate masked iron deficiency.

What it isA composite ratio combining iron-stores/inflammation (ferritin) and synthetic/nutritional state (albumin).

DoesCaptures the catabolic phenotype of chronic disease.

GoodA low ratio signals balanced iron, low inflammation, and good nutrition.

BadA high ratio predicts mortality in cancer, chronic kidney disease, and heart failure.

What it isIL-6 is a pleiotropic cytokine released by immune cells, fat cells, and contracting muscle. It drives the liver's CRP response and shapes both acute and chronic inflammation.

DoesTriggers acute-phase responses, regulates immune cell development, and acts as a long-distance signal in inflammation.

GoodLow circulating IL-6 signals quiescent chronic inflammation and predicts healthy aging.

BadChronically elevated IL-6 is a hallmark of "inflammaging" — the slow-burn inflammation of aging — and predicts cardiovascular events, frailty, dementia, and cancer.

What it isA protein released by activated macrophages that promotes inflammation and tissue fibrosis. It is elevated in failing hearts and aging tissues.

DoesDrives fibroblast activation and scarring across heart, kidney, liver, and lungs.

GoodLow galectin-3 signals minimal active fibrotic remodeling.

BadElevated galectin-3 predicts heart failure progression, cardiovascular mortality, and accelerated aging through tissue fibrosis.

What it isThe number of red blood cells per microliter of blood. Red cells are made in the bone marrow under the control of erythropoietin from the kidneys and live about 120 days.

DoesCarry oxygen from lungs to tissues and carbon dioxide back.

GoodA mid-range RBC count reflects healthy marrow, sufficient iron and B vitamins, and adequate kidney signaling.

BadLow RBC means anemia — fatigue, reduced exercise capacity, cognitive fog. High RBC (polycythemia) raises clotting risk and is sometimes driven by sleep apnea, smoking, or testosterone therapy.

What it isHemoglobin is the iron-containing protein inside red blood cells that binds and releases oxygen. Each red cell carries roughly 270 million hemoglobin molecules.

DoesPicks up oxygen in the lungs and releases it where oxygen tension is low — primarily metabolically active tissues.

GoodMid-range hemoglobin signals robust oxygen-carrying capacity and supports exercise performance, cognition, and tissue repair.

BadLow hemoglobin causes anemia, fatigue, and reduced exercise capacity. Very high hemoglobin raises blood viscosity and clotting risk.

What it isThe percentage of total blood volume occupied by red blood cells, after spinning the sample down in a centrifuge.

DoesCaptures the same information as RBC count and hemoglobin but in a different form; helps assess blood viscosity.

GoodMid-range hematocrit balances oxygen-carrying capacity against blood viscosity.

BadLow hematocrit signals anemia. High hematocrit increases blood viscosity and clotting risk — common with testosterone therapy, sleep apnea, smoking, and high altitude.

What it isThe average size of a single red blood cell, measured in femtoliters.

DoesClassifies anemia by red cell size and points toward the underlying cause.

GoodA mid-range MCV indicates normally-sized cells and signals balanced iron and B vitamin status.

BadLow MCV (microcytic) flags iron deficiency or thalassemia. High MCV (macrocytic) flags B12 or folate deficiency, alcohol use, or hypothyroidism.

What it isThe average mass of hemoglobin packed inside a single red blood cell.

DoesHelps classify anemia by red cell hemoglobin content.

GoodA mid-range MCH signals red cells filled with appropriate hemoglobin.

BadLow MCH usually accompanies low MCV in iron deficiency or thalassemia.

What it isThe concentration of hemoglobin inside the red cell, calculated by dividing hemoglobin by hematocrit.

DoesCaptures hemoglobin density per unit cell volume.

GoodA mid-range MCHC indicates well-packed, oxygen-loaded red cells.

BadLow MCHC accompanies iron deficiency. High MCHC suggests hereditary spherocytosis or cold agglutinin disease.

What it isThe coefficient of variation of red blood cell sizes — how uniformly sized the red cells are in a sample. Low RDW means uniform cells; high RDW means a mix of sizes.

DoesCaptures the diversity of red cell ages and sources, which reflects the smoothness of marrow production.

GoodA low RDW signals consistent erythropoiesis and tracks lower all-cause mortality.

BadElevated RDW is one of the strongest single markers of all-cause mortality, even within the "normal" range. It rises before anemia in iron, B12, or folate deficiency.

What it isA calculated ratio that combines red cell size variability and average size into one number.

DoesHighlights subtle perturbations in red cell biology that neither marker captures alone.

GoodA low ratio signals smooth, uniform erythropoiesis.

BadA high ratio has been linked with all-cause mortality and aging.

What it isA calculated ratio of red cell variability to ferritin that can flag iron deficiency masked by inflammation.

DoesHelps disentangle hidden iron deficiency when ferritin is artificially elevated by inflammation.

GoodA balanced ratio suggests appropriate iron status without significant erythropoiesis stress.

BadA high ratio in someone with normal-appearing ferritin suggests masked iron deficiency or chronic inflammation.

What it isTotal count of all immune cells per microliter — neutrophils, lymphocytes, monocytes, eosinophils, basophils.

DoesDefends against pathogens, surveys for cancer, mediates inflammation and repair.

GoodA mid-low WBC count in a healthy person predicts the lowest all-cause mortality and reflects low chronic inflammation.

BadElevated WBC marks infection, inflammation, stress, or marrow disorders, and elevated baseline WBC predicts cardiovascular events. Very low WBC raises infection risk and can signal marrow failure or autoimmune disease.

What it isNeutrophils are the most abundant white blood cell, made in the bone marrow. They circulate briefly before migrating into tissues to engulf and kill bacteria and fungi.

DoesServe as the first responders of innate immunity, particularly against bacterial and fungal infections.

GoodA mid-range neutrophil count signals balanced immunity ready to respond without excess inflammation.

BadElevated neutrophils indicate bacterial infection, acute inflammation, physiological stress, smoking, or steroid effects. Sustained elevation predicts cardiovascular disease. Very low counts (neutropenia) raise serious infection risk.

What it isLymphocytes — T cells, B cells, and natural killer cells — are the cellular workforce of adaptive immunity. They identify specific threats and orchestrate the immune response.

DoesRecognize and remember specific pathogens, kill infected cells, produce antibodies, and patrol for cancer.

GoodA robust lymphocyte count signals intact adaptive immunity and predicts lower all-cause mortality.

BadLow lymphocyte count (lymphopenia) predicts mortality across nearly every chronic disease and signals immune exhaustion, often from chronic inflammation, chronic infection, or steroid use.

What it isMonocytes are large white blood cells that circulate for a few days before entering tissues, where they mature into macrophages and dendritic cells.

DoesClean up debris, present antigens to T cells, fight chronic infections, and drive tissue remodeling.

GoodA mid-range monocyte count signals balanced tissue immune surveillance.

BadElevated monocytes indicate chronic inflammation, chronic infection, autoimmune disease, or atherosclerosis. Sustained elevation tracks cardiovascular risk.

What it isEosinophils are granulocytes specialized for fighting parasites and mediating allergic reactions.

DoesRelease toxic granules against parasites and amplify allergic inflammation.

GoodA low eosinophil count signals quiescent allergic activity and absence of parasitic infection.

BadElevated eosinophils indicate allergic disease (asthma, eczema, food sensitivities), parasitic infection, drug reactions, or rare hypereosinophilic disorders.

What it isThe rarest white blood cell type. Basophils release histamine and other inflammatory mediators during allergic reactions.

DoesAmplify allergic and chronic inflammatory responses.

GoodA low or absent basophil count is normal and reflects quiescent allergic biology.

BadElevated basophils flag chronic allergic inflammation, chronic myeloid leukemia, or other rare myeloproliferative disorders.

What it isA simple ratio of neutrophils to lymphocytes that captures the balance between innate inflammatory activation and adaptive immune competence.

DoesIndexes systemic inflammation and immune exhaustion in a single number.

GoodA low NLR signals balanced immunity and predicts the lowest cardiovascular and cancer mortality.

BadElevated NLR predicts mortality across cardiovascular disease, cancer, sepsis, and aging. It rises with stress, infection, and chronic inflammation.

What it isA ratio of platelet count to lymphocyte count that captures the intersection of clotting tendency and immune balance.

DoesCombines two readily-available numbers into a stronger predictor than either alone.

GoodA low PLR signals balanced thrombotic and immune biology.

BadElevated PLR predicts cardiovascular events, cancer outcomes, and mortality.

What it isA calculated composite using platelets, neutrophils, and lymphocytes that captures inflammation and immune balance in one number.

DoesIntegrates three independent prognostic markers into a stronger composite predictor.

GoodA low SII signals balanced immune-inflammatory tone and tracks better outcomes across diseases.

BadElevated SII predicts mortality in cancer, cardiovascular disease, and chronic inflammation.

What it isA newer composite combining monocytes, neutrophils, and lymphocytes to capture systemic inflammation.

DoesIndexes innate inflammation against adaptive competence.

GoodA low SIRI signals quiescent inflammation and a healthy immune system.

BadElevated SIRI predicts mortality in cardiovascular disease, cancer, and chronic illness.

What it isThe ratio of lymphocytes to monocytes — adaptive immune competence against innate inflammatory drive.

DoesCaptures immune balance in a single number.

GoodA high ratio signals strong adaptive immunity relative to inflammatory activity and predicts better cancer outcomes.

BadA low ratio tracks chronic inflammation and worse prognosis in cancer, cardiovascular disease, and sepsis.

What it isA calculated ratio of monocytes to HDL cholesterol that captures the balance between vascular inflammatory drive and reverse cholesterol transport.

DoesCombines two cardiovascular predictors into a stronger composite.

GoodA low MHR signals balanced vascular biology.

BadElevated MHR predicts cardiovascular events, metabolic syndrome, and atherosclerosis progression.

What it isPlatelets are tiny cell fragments shed from megakaryocytes in the bone marrow. They circulate for about 10 days and form clots at sites of vessel injury.

DoesPlug holes in damaged vessels and trigger the clotting cascade; also participate in inflammation.

GoodA mid-range platelet count balances clotting capacity against thrombotic risk.

BadLow platelets (thrombocytopenia) raise bleeding risk. High platelets indicate inflammation, iron deficiency, or rare myeloproliferative disorders, and elevated counts predict cardiovascular events.

What it isThe average size of platelets in circulation. Younger, freshly released platelets are larger and more thrombotically active.

DoesCaptures platelet age and reactivity.

GoodA mid-range MPV signals normal platelet turnover.

BadHigh MPV indicates accelerated platelet production with more reactive young platelets and tracks cardiovascular events. Low MPV can signal marrow suppression.

What it isFerritin is the body's iron storage protein. Most of it sits inside cells; a small fraction in blood reflects body iron reserves. It's also an acute-phase reactant that rises with inflammation.

DoesStores iron in a non-toxic form and releases it when the body needs to make hemoglobin, myoglobin, and iron-containing enzymes.

GoodMid-range ferritin signals adequate iron reserves without overload.

BadLow ferritin signals iron deficiency — fatigue, hair loss, restless legs, exercise intolerance, brain fog — often before anemia develops. Very high ferritin signals iron overload (hemochromatosis), inflammation, or liver disease and drives oxidative damage.

What it isThe total amount of iron circulating in blood bound to transferrin. Iron is essential for hemoglobin, myoglobin, and many enzymes.

DoesTransports iron from gut absorption and red cell turnover to bone marrow and other tissues.

GoodMid-range iron with appropriate ferritin signals balanced iron handling.

BadLow serum iron with low ferritin confirms iron deficiency. High iron with high transferrin saturation suggests hemochromatosis.

What it isTIBC measures the total amount of iron transferrin can carry — essentially a proxy for transferrin levels.

DoesReports the body's iron-transport capacity.

GoodMid-range TIBC with appropriate iron and ferritin signals balanced iron status.

BadTIBC rises in iron deficiency (the body upregulates transferrin to grab more iron) and falls in chronic disease and inflammation.

What it isTransferrin is the liver-made protein that carries iron through the bloodstream. Direct measurement of transferrin parallels TIBC.

DoesTransports iron from gut and recycled red cells to bone marrow and tissues.

GoodMid-range transferrin signals balanced iron transport.

BadRises in iron deficiency; falls in chronic disease, inflammation, malnutrition, and liver failure.

What it isThe percentage of transferrin that is currently carrying iron, calculated as serum iron divided by TIBC.

DoesReports the loading state of the iron transport system.

GoodMid-range saturation signals balanced iron handling.

BadLow saturation (<20%) confirms iron deficiency. Persistently high saturation (>45%) is the primary screen for hereditary hemochromatosis and drives organ damage from iron overload.

What it isReticulocytes are newly released red blood cells that still contain some RNA. Their proportion in blood reflects how briskly the bone marrow is producing red cells.

DoesIndexes erythropoiesis.

GoodA mid-range reticulocyte count signals appropriate baseline red cell production.

BadLow reticulocytes in anemia suggest marrow failure or iron/B12/folate deficiency. High reticulocytes in anemia suggest the marrow is appropriately responding to blood loss or hemolysis.

What it isA fragment of the transferrin receptor that iron-hungry cells release into blood. The hungrier the body's tissues are for iron, the more sTfR appears.

DoesReports cellular iron demand independent of inflammation.

GoodMid-range sTfR signals balanced iron supply and demand.

BadHigh sTfR confirms iron deficiency even when ferritin is elevated by inflammation — the cleanest tool to disentangle these.

What it isTSH is released by the pituitary gland in response to falling circulating thyroid hormone. It instructs the thyroid to make and release more T4 and T3.

DoesActs as the body's thermostat for thyroid output — rising when thyroid hormone is low, falling when it's adequate.

GoodA mid-low TSH with adequate Free T4 and Free T3 signals a smoothly running thyroid axis.

BadHigh TSH signals hypothyroidism (the thyroid isn't keeping up). Low TSH suggests hyperthyroidism or, less commonly, pituitary failure.

What it isFree T4 is the fraction of thyroxine that isn't bound to transport proteins. The thyroid secretes T4 as the storage form; tissues take it up and convert it to active T3.

DoesProvides the substrate pool the body converts to active thyroid hormone wherever and whenever it's needed.

GoodFree T4 in the upper-mid normal range signals robust thyroid output and adequate substrate for tissue conversion.

BadLow Free T4 indicates hypothyroidism; high Free T4 indicates hyperthyroidism. Patterns that diverge from TSH expectations suggest pituitary or conversion problems.

What it isFree T3 is the unbound, biologically active form of thyroid hormone. Most T3 is generated by removing an iodine atom from T4 in peripheral tissues; a small amount comes directly from the thyroid.

DoesBinds to nuclear receptors and drives metabolic rate, body temperature, heart rate, cognition, mood, and protein synthesis.

GoodFree T3 in the upper-mid range signals efficient T4-to-T3 conversion and intact tissue thyroid hormone action.

BadLow Free T3 with normal Free T4 suggests impaired conversion ("low T3 syndrome") and tracks fatigue, depression, weight gain, and cognitive sluggishness.

What it isThe combined measurement of T4 that is bound to transport proteins plus the small free fraction.

DoesReports the full T4 pool, but doesn't distinguish active from inactive bound hormone.

GoodA mid-range total T4 with normal free T4 suggests balanced thyroid output and transport protein levels.

BadDistortions from estrogen, pregnancy, or liver disease that shift transport proteins make total T4 misleading — Free T4 is the more reliable measure.

What it isThe combined measurement of T3 that is bound to transport proteins plus the small free fraction.

DoesReports the full T3 pool, but is less clinically informative than Free T3.

GoodA mid-range total T3 with normal Free T3 suggests adequate tissue thyroid hormone availability.

BadSame transport protein distortions as Total T4 apply.

What it isReverse T3 is an inactive metabolite produced when peripheral tissues remove the wrong iodine atom from T4. The body uses this alternate pathway to ramp down thyroid hormone activity during stress, fasting, or illness.

DoesFunctions as a brake on metabolic activity by competing with active T3 at receptors.

GoodLow rT3 signals that the body isn't redirecting T4 into the inactive pathway.

BadElevated rT3 — especially with low Free T3 — defines "low T3 syndrome" and tracks chronic stress, illness, low-calorie states, overtraining, and inflammation.

What it isA ratio that captures the balance between active T3 production and inactive rT3 diversion in peripheral tissues.

DoesIndexes functional thyroid status at the tissue level — what's actually getting through to receptors.

GoodA high ratio signals strong active thyroid hormone availability and a metabolism running smoothly.

BadA low ratio indicates impaired conversion and tracks fatigue, weight gain, cognitive sluggishness, and chronic stress states.

What it isA legacy calculation combining total T4 with T3 uptake to estimate free T4 indirectly before direct free T4 assays existed.

DoesProvides a back-calculated estimate of biologically available T4.

GoodA mid-range FTI tracks normal free T4.

BadLargely superseded by direct Free T4 measurement; rarely needed today.

What it isA legacy test that indirectly measures available thyroid-binding protein capacity by competing radiolabeled T3 against the patient's own thyroid hormones.

DoesProvides one of the inputs into the legacy Free T4 Index calculation.

GoodA mid-range value with normal Free T4 indicates balanced transport protein levels.

BadLargely superseded by direct Free T4 measurement.

What it isAutoantibodies that target thyroid peroxidase, the enzyme that builds thyroid hormone. Their presence indicates an autoimmune attack on the thyroid gland.

DoesDrive the autoimmune destruction of thyroid tissue, marking Hashimoto's thyroiditis (and sometimes Graves' disease).

GoodAbsent or low antibodies signal an unaffected thyroid gland.

BadElevated TPO antibodies predict progression to overt hypothyroidism, even when thyroid hormone levels are still normal.

What it isAutoantibodies that target thyroglobulin, the storage protein the thyroid uses to make T4 and T3.

DoesMark autoimmune thyroid disease and interfere with thyroglobulin measurement during thyroid cancer follow-up.

GoodAbsent or low antibodies indicate no autoimmune thyroid attack.

BadElevated TgAb signals Hashimoto's thyroiditis; in thyroid cancer monitoring, these antibodies invalidate thyroglobulin tumor marker readings.

What it isThyroglobulin is the storage protein within the thyroid follicle where T4 and T3 are made. Small amounts leak into circulation.

DoesActs as a tumor marker after thyroid cancer treatment — detectable thyroglobulin after total thyroidectomy and radioiodine ablation suggests residual or recurrent disease.

GoodUndetectable in post-treatment thyroid cancer patients signals successful eradication.

BadDetectable thyroglobulin in those settings flags recurrence; also rises in benign thyroid conditions.

What it isAutoantibodies that bind and activate the TSH receptor on thyroid cells, mimicking TSH and driving uncontrolled thyroid hormone production.

DoesDrive the autoimmune hyperthyroidism of Graves' disease.

GoodAbsent antibodies signal no Graves' disease.

BadElevated TRAb confirms Graves' disease; very high levels suggest more severe or longer-lasting disease and predict relapse after treatment.

What it isALT is an enzyme concentrated inside hepatocytes — liver cells — that catalyzes a key step in amino acid metabolism. When liver cells are damaged, ALT leaks into the bloodstream.

DoesActs as the most specific blood marker of liver cell injury.

GoodLow ALT signals healthy hepatocytes and minimal liver stress.

BadElevated ALT marks fatty liver, viral hepatitis, alcohol injury, drug toxicity, and ischemic damage. Even mildly elevated ALT predicts metabolic disease and mortality.

What it isAST is an enzyme found in liver, heart, skeletal muscle, kidney, and red blood cells. Like ALT, it catalyzes an amino acid metabolism step and leaks into the bloodstream when its host cells are damaged.

DoesReports cell injury — but from any of several tissues, not just liver.

GoodLow AST signals healthy liver and muscle without ongoing damage.

BadElevated AST flags liver disease, muscle injury, cardiac damage, or hemolysis. When AST rises higher than ALT, alcoholic liver disease is the leading suspect.

What it isA simple ratio of AST to ALT that fingerprints the type of liver injury when both enzymes are elevated.

DoesDistinguishes alcoholic liver injury (high ratio) from non-alcoholic fatty liver disease (low ratio) and tracks the progression to fibrosis.

GoodA ratio near 1.0 with both enzymes in the optimal range signals healthy liver biology.

BadA ratio >2 with elevated enzymes strongly suggests alcoholic liver disease; a ratio <1 with elevated enzymes is the fatty liver signature. A rising ratio over time suggests advancing fibrosis.

What it isALP is a family of enzymes anchored to cell membranes in the liver, bile ducts, bone, intestine, and placenta. Total blood ALP combines contributions from all sources.

DoesRemoves phosphate groups in alkaline environments; rises when bile flow is obstructed or bone turnover increases.

GoodA mid-range level signals normal bile flow and quiescent bone remodeling.

BadElevation suggests bile duct obstruction, liver disease, accelerated bone turnover, or vitamin D deficiency. Very low ALP can indicate zinc, magnesium, or B6 deficiency, or hypophosphatasia.

What it isGGT is a liver and bile duct enzyme that helps the body recycle glutathione, its master antioxidant. It is exquisitely sensitive to alcohol and to oxidative stress in the liver.

DoesTracks alcohol exposure, oxidative stress, and bile flow.

GoodLow GGT signals minimal alcohol exposure, low oxidative stress, and patent bile ducts.

BadElevated GGT marks alcohol use, fatty liver, medication effects, and oxidative stress. Even within the normal range, rising GGT predicts cardiovascular events, type 2 diabetes, and all-cause mortality.

What it isBilirubin is the orange-yellow pigment produced when red blood cells are broken down and hemoglobin is recycled. The liver conjugates it and excretes it into bile.

DoesFunctions as a potent antioxidant in circulation; gives bile and stool their color.

GoodA mid-range bilirubin provides antioxidant benefit without signaling pathology. Slightly elevated bilirubin (often Gilbert's syndrome) is associated with reduced cardiovascular and cancer risk.

BadVery high bilirubin signals liver disease, bile duct obstruction, or hemolysis. Very low bilirubin may indicate inflammation and depleted antioxidant capacity.

What it isThe fraction of bilirubin that has been processed (conjugated) by the liver and is water-soluble, ready for excretion into bile.

DoesTravels from the liver through bile ducts to the intestine for elimination.

GoodLow direct bilirubin signals patent bile flow and healthy liver clearance.

BadElevated direct bilirubin specifically signals bile duct obstruction, liver cell damage interfering with bile excretion, or rare inherited disorders.

What it isThe fraction of bilirubin that has not yet been conjugated by the liver. It travels bound to albumin from the spleen to the liver.

DoesAwaits liver processing; in circulation, acts as an antioxidant.

GoodA mid-range level signals normal red cell turnover and adequate liver uptake capacity.

BadElevated indirect bilirubin indicates accelerated red cell breakdown (hemolysis) or Gilbert's syndrome — a benign genetic variation that slightly slows conjugation.

What it isAlbumin is the most abundant protein in blood plasma, manufactured exclusively by the liver. It functions as the body's primary carrier of fatty acids, hormones, calcium, drugs, and bilirubin.

DoesMaintains oncotic pressure to keep fluid inside blood vessels; transports a vast array of molecules; serves as a circulating amino acid reservoir.

GoodHigh-normal albumin signals robust liver synthesis, adequate protein nutrition, low inflammation, and is one of the strongest single predictors of longevity.

BadLow albumin marks chronic inflammation, malnutrition, liver disease, kidney protein loss, or frailty. It predicts mortality across nearly every disease category.

What it isThe sum of albumin and all globulins (antibodies, transport proteins, clotting factors) in blood. It captures the overall protein content of plasma.

DoesMaintains oncotic pressure, immune, transport, and clotting.

GoodA mid-range total protein with appropriate albumin and globulin fractions indicates intact synthesis and immune balance.

BadLow total protein signals malnutrition, liver failure, or protein loss; very high total protein can indicate chronic inflammation, multiple myeloma, or other monoclonal gammopathies.

What it isThe fraction of plasma protein that isn't albumin — antibodies (immunoglobulins), complement, transport proteins, and clotting factors.

DoesCarries out immune defense, transport, and coagulation.

GoodA mid-low globulin level signals quiescent immune activation and absence of chronic inflammation.

BadElevated globulin reflects chronic infection, autoimmunity, chronic inflammation, or plasma cell disorders like multiple myeloma. Low globulin signals immunodeficiency.

What it isA simple ratio of albumin to globulin that captures the balance between liver synthetic and immune/inflammatory activity.

DoesHighlights cases where total protein looks fine but the composition is off.

GoodA high ratio (lots of albumin, low globulin) signals good liver, low chronic inflammation, and is associated with longevity.

BadA low ratio suggests chronic inflammation, infection, autoimmunity, or plasma cell disorders.

What it isA composite ratio of bilirubin to albumin that captures liver and nutritional state in a single number.

DoesCombines two strong independent prognostic markers into a more powerful predictor of outcomes in chronic disease.

GoodA low BAR signals good liver and adequate protein status.

BadA high BAR predicts mortality in liver disease, cancer, sepsis, and chronic illness generally.

What it isCreatinine is a breakdown product of creatine, the energy-buffer molecule found in skeletal muscle. It is produced at a steady rate proportional to muscle mass and is cleared by the kidneys via glomerular filtration.

DoesActs as a workhorse marker of glomerular filtration; the kidneys must filter it continuously to keep blood levels stable.

GoodA stable mid-range creatinine relative to your muscle mass signals intact kidney filtration.

BadRising creatinine indicates failing kidney filtration. Very low creatinine in someone with normal kidneys often signals low muscle mass — a frailty signal.

What it isBUN measures the nitrogen content of urea, the molecule the liver creates to package and excrete the nitrogen waste from protein metabolism. Kidneys filter it out.

DoesReflects the intersection of protein intake, liver urea synthesis, kidney filtration, and hydration status.

GoodA mid-range BUN signals balanced protein metabolism, intact liver and kidney, and good hydration.

BadHigh BUN signals dehydration, high protein intake, kidney impairment, or gastrointestinal bleeding. Low BUN can indicate low protein intake or liver dysfunction.

What it isA simple ratio of BUN to creatinine that helps distinguish pre-renal causes of elevated BUN (dehydration, bleeding) from intrinsic kidney disease.

DoesActs as a diagnostic clue when BUN is elevated — same BUN, different ratio, different story.

GoodA mid-range ratio with both components in their optimal ranges indicates balanced hydration and intact kidney.

BadA high ratio with normal creatinine suggests dehydration or upper GI bleed; a low ratio suggests low protein intake or liver disease; a high ratio with elevated creatinine suggests prerenal kidney injury.

What it isA calculated estimate of how much blood the kidneys filter per minute, derived from creatinine adjusted for age and sex.

DoesServes as the standard staging metric for chronic kidney disease.

GoodA high eGFR signals robust filtration and a wide kidney reserve, predicting longevity and tolerance of drugs cleared by the kidneys.

BadFalling eGFR signals chronic kidney disease, predicts cardiovascular events, mortality, and eventually need for dialysis.

What it isCystatin C is a small protein produced by virtually every nucleated cell at a stable rate, independent of muscle mass. It is freely filtered by the kidneys and then degraded.

DoesProvides a cleaner readout of kidney filtration than creatinine because muscle mass doesn't distort it.

GoodLow cystatin C signals strong kidney filtration and predicts longevity.

BadElevated cystatin C detects early kidney decline that creatinine misses, and independently predicts cardiovascular events and mortality.

What it isA calculated filtration rate derived from cystatin C rather than creatinine, providing a muscle-independent estimate.

DoesCross-checks creatinine-based eGFR, which can mislead at extremes of muscle mass.

GoodA high value confirms strong filtration capacity.

BadWhen creatinine-based eGFR looks fine but cystatin C–based eGFR is low, kidney may be worse than it appears.

What it isA urine test measuring small amounts of albumin that have leaked through the glomerulus into urine, normalized to urine creatinine. The kidney filter normally holds back almost all albumin.

DoesDetects early kidney damage at the glomerular barrier — a leaky filter.

GoodA very low ratio confirms an intact filtration barrier and predicts cardiovascular and kidney longevity.

BadMicroalbuminuria is the earliest detectable sign of diabetic or hypertensive kidney damage and an independent cardiovascular risk marker.

What it isAn older equation estimating kidney filtration from creatinine, age, weight, and sex. Drug dosing labels still use it for many medications.

DoesProvides the historical reference for renal drug dose adjustment.

GoodA high value confirms adequate filtration capacity for handling renally cleared drugs.

BadLow values trigger dose reductions for many medications to prevent toxicity.

What it isCortisol is the body's primary glucocorticoid, produced by the adrenal cortex under pituitary direction. It peaks within 30–60 minutes of waking — the cortisol awakening response.

DoesMobilizes glucose, modulates immune, sharpens focus, and drives the circadian arousal pattern.

GoodA robust morning cortisol signal predicts strong daytime energy and intact stress response.

BadPersistently elevated AM cortisol drives insulin resistance, visceral fat, sleep disruption, immune suppression, and bone loss. Very low AM cortisol signals adrenal insufficiency or HPA axis suppression.

What it isCortisol measured later in the day, ideally evening. Healthy cortisol follows a diurnal curve that falls sharply through the day.

DoesProvides the second data point needed to characterize the diurnal cortisol pattern.

GoodA low PM cortisol confirms a clean diurnal curve and supports good sleep.

BadElevated PM cortisol signals HPA axis dysregulation from chronic stress, late-day caffeine, alcohol, or sleep disturbance — and predicts insomnia, weight gain, and impaired recovery.

What it isDHEA-S is the most abundant circulating steroid in the body, produced primarily by the adrenal glands. It serves as a reservoir from which sex hormones can be synthesized.

DoesProvides substrate for both androgen and estrogen pathways; supports immune, mood, libido, and bone density.

GoodHigh-normal DHEA-S signals strong adrenal output and tracks biological youth.

BadLow DHEA-S correlates with chronological aging, chronic stress, and frailty. Very high DHEA-S in women suggests PCOS or adrenal androgen excess.

What it isA ratio of catabolic stress hormone (cortisol) to anabolic adrenal reserve (DHEA-S) that captures the balance between stress and resilience.

DoesIndexes net adrenal output direction — catabolic versus anabolic.

GoodA low ratio signals balanced adrenal with robust reserve.

BadA high ratio reflects chronic stress dominance over reserve and tracks accelerated biological aging, immune dysfunction, and depression.

What it isPregnenolone is the "mother steroid" — the immediate downstream product of cholesterol from which all other steroid hormones are made.

DoesProvides substrate for cortisol, DHEA, progesterone, and downstream sex hormones; also acts directly as a neurosteroid affecting GABA receptors.

GoodMid-range pregnenolone signals adequate substrate for steroid synthesis and supports mood, memory, and resilience.

BadLow pregnenolone tracks aging and chronic stress and may contribute to cognitive sluggishness and mood instability.

What it isAldosterone is the adrenal hormone that regulates sodium retention and potassium excretion in the kidney, controlling blood volume and blood pressure.

DoesDrives sodium reabsorption (and water with it) in the distal nephron, expanding blood volume.

GoodA mid-range aldosterone signals balanced volume control.

BadElevated aldosterone drives hypertension, low potassium, and cardiovascular damage. Primary aldosteronism is an underdiagnosed cause of resistant hypertension.

What it isAn enzyme released by specialized kidney cells when they sense low blood pressure or low sodium. It cleaves angiotensinogen to start the renin-angiotensin-aldosterone cascade.

DoesInitiates aldosterone release, vasoconstriction, and sodium retention.

GoodA mid-range renin alongside appropriate aldosterone signals balanced volume regulation.

BadSuppressed renin with high aldosterone signals primary aldosteronism. High renin signals dehydration, kidney artery stenosis, or appropriate response to drugs.

What it isThe total amount of testosterone in blood, including the small free fraction and the much larger bound fraction attached to SHBG and albumin. The testes make the vast majority in men; small amounts come from the adrenals.

DoesDrives muscle protein synthesis, libido, energy, mood, red blood cell production, bone density, and metabolic health.

GoodMid-high total testosterone signals robust gonadal and tracks lean body composition, strength, libido, and energy.

BadLow testosterone (hypogonadism) drives fatigue, low libido, depression, muscle loss, bone loss, and metabolic dysfunction. Very high in men not on TRT can rarely signal androgen-secreting tumors.

What it isThe fraction of testosterone not bound to transport proteins — the portion freely available to enter cells and bind androgen receptors.

DoesProvides the functionally active testosterone reaching tissues; SHBG variations make total testosterone a poor proxy in some men.

GoodMid-high free testosterone signals robust androgen signaling at the tissue level and tracks muscle mass, libido, energy, and metabolic health.

BadLow free testosterone — even with normal total testosterone — drives all hypogonadal symptoms. Common in older men with high SHBG.

What it isThe sum of free testosterone plus testosterone loosely bound to albumin, which dissociates readily and is available to tissues.

DoesRepresents the most accurate measure of testosterone that can actually act on receptors.

GoodA high bioavailable testosterone signals strong tissue-level androgen action.

BadLow bioavailable testosterone drives hypogonadal symptoms — fatigue, low libido, muscle loss — even if total testosterone reads normal.

What it isSHBG is a liver-made protein that binds testosterone and estradiol with high affinity, sequestering them away from tissues. Its level is regulated by insulin, thyroid hormone, estrogen, and liver.

DoesActs as the body's sex hormone buffer — when SHBG goes up, the bound fraction rises and free, active hormone falls.

GoodA mid-range SHBG allows the bound and free fractions to coexist in a healthy balance.

BadLow SHBG signals insulin resistance, fatty liver, or hyperthyroidism — and allows free testosterone to spike high relative to total. High SHBG (common with age, hyperthyroidism, low calorie states) lowers free testosterone despite normal totals.

What it isA calculated estimate of free testosterone derived from total testosterone divided by SHBG and multiplied by 100.

DoesApproximates the free testosterone fraction when direct measurement isn't available.

GoodA high FAI in men signals strong functional androgen action.

BadA low FAI in men signals functional hypogonadism. In women, a high FAI signals androgen excess (PCOS, hirsutism).

What it isDHT is testosterone's more potent cousin, produced when 5α-reductase enzymes remove a double bond. It binds androgen receptors more tightly than testosterone itself.

DoesDrives prostate growth, scalp hair loss, beard and body hair, and sebum production. Critical for male sexual development.

GoodA mid-range DHT signals balanced androgen signaling without excess prostate or hair follicle stimulation.

BadHigh DHT drives male pattern hair loss and prostate enlargement. Very low DHT can blunt libido and sexual even when testosterone is adequate.

What it isEstradiol is the most potent estrogen and matters in men, not just women. The aromatase enzyme converts testosterone to estradiol in fat, bone, and brain tissue.

DoesSupports bone density, libido, cognitive, and lipid health in men. Too little or too much disrupts these systems.

GoodA mid-range estradiol signals balanced aromatization and supports bone, mood, and libido.

BadHigh estradiol in men drives gynecomastia, water retention, and emotional volatility — common with TRT and visceral obesity. Crushing estradiol with aromatase inhibitors causes joint pain, low libido, bone loss, and mood crashes.

What it isA pituitary hormone that stimulates spermatogenesis in the testes by acting on Sertoli cells.

DoesDrives sperm production and supports testicular volume.

GoodA mid-range FSH alongside normal testosterone signals an intact pituitary-gonadal axis.

BadHigh FSH with low testosterone indicates testicular failure (primary hypogonadism). Low FSH with low testosterone indicates pituitary failure (secondary hypogonadism). Exogenous testosterone suppresses FSH to undetectable.

What it isA pituitary hormone that signals the Leydig cells of the testes to manufacture testosterone.

DoesDrives testicular testosterone production.

GoodA mid-range LH with normal testosterone signals an intact pituitary-gonadal axis.

BadHigh LH with low testosterone signals primary testicular failure. Low LH with low testosterone signals secondary (pituitary or hypothalamic) failure. Exogenous testosterone suppresses LH and shrinks the testes.

What it isA pituitary hormone primarily known for milk production in women but present and active in men too.

DoesSuppresses gonadotropin-releasing hormone, which lowers LH/FSH and therefore testosterone. Also influences libido, refractory period after orgasm, and immune.

GoodA mid-low prolactin signals an unobstructed gonadal axis and intact libido.

BadElevated prolactin in men suppresses testosterone, causes erectile dysfunction, low libido, and possibly gynecomastia. Very high levels suggest a pituitary tumor (prolactinoma).

What it isPSA is an enzyme produced almost exclusively by prostate cells. Small amounts leak into the bloodstream normally; more leaks when the prostate is inflamed, enlarged, or has cancer.

DoesLiquefies semen physiologically; serves as a tumor marker for prostate cancer.

GoodA low, stable PSA tracks the absence of clinically significant prostate cancer.

BadRising or elevated PSA flags benign prostatic hyperplasia, prostatitis, or prostate cancer. PSA velocity and density add specificity beyond the single number.

What it isThe fraction of PSA that circulates unbound to other proteins. Cancer cells produce more of the bound form, so free PSA percentage helps distinguish benign from malignant elevations.

DoesRefines PSA interpretation when total PSA is in the diagnostic gray zone.

GoodA high percentage of free PSA suggests benign causes — BPH or prostatitis.

BadA low percentage of free PSA raises concern for prostate cancer and triggers further evaluation.

What it isEstradiol is the most potent estrogen, made primarily by growing ovarian follicles. Levels swing dramatically through the menstrual cycle and plummet at menopause.

DoesDrives endometrial growth, bone density, cardiovascular health, cognition, mood, libido, skin elasticity, and vaginal tissue health.

GoodCycle-appropriate estradiol signals normal ovarian and supports bone, brain, vascular, and reproductive health.

BadLow estradiol — premature ovarian insufficiency or postmenopause — drives hot flashes, bone loss, brain fog, mood instability, and vaginal atrophy. Persistently high estradiol can drive heavy bleeding and increase breast cancer risk.

What it isA higher-sensitivity estradiol assay (typically mass spectrometry) accurate at the low concentrations found in postmenopausal women, men, and children.

DoesProvides accurate measurement when standard E2 assays read at the floor of their dynamic range.

GoodCycle-appropriate or HRT-target levels signal adequate estrogen action.

BadFalsely high readings from standard assays at low concentrations mislead postmenopausal HRT dosing.

What it isEstrone is a weaker estrogen produced primarily by aromatase in fat tissue. After menopause, when ovarian estradiol drops, estrone becomes the dominant circulating estrogen.

DoesProvides background estrogenic activity, particularly important in postmenopausal women.

GoodMid-range estrone signals balanced adipose estrogen production.

BadHigh estrone can drive endometrial hyperplasia and breast cancer risk in postmenopausal women with excess body fat. Very low estrone in postmenopause contributes to bone loss.

What it isEstriol is the weakest of the three main estrogens and dominates during pregnancy, when the placenta produces it in large amounts.

DoesSupports the pregnant uterus and maternal physiology; used in some HRT formulations for vaginal symptoms.

GoodPregnancy-appropriate levels signal placental health.

BadOutside pregnancy, levels are very low and not typically clinically meaningful.

What it isProgesterone is the dominant hormone of the luteal phase after ovulation. The corpus luteum makes it from the collapsed ovarian follicle; the placenta later takes over during pregnancy.

DoesPrepares the endometrium for implantation, supports early pregnancy, balances estrogen, promotes calm and sleep, supports thyroid.

GoodHigh mid-luteal progesterone confirms ovulation and predicts a fertile cycle.

BadLow luteal progesterone signals anovulation or luteal phase defect — common in PCOS, perimenopause, hypothalamic amenorrhea — and tracks heavy bleeding, mood instability, and infertility.

What it isA pituitary hormone that stimulates ovarian follicles to grow. The brain raises FSH when ovarian reserve falls.

DoesDrives follicular development and estrogen production each cycle.

GoodLow day-3 FSH signals strong ovarian reserve and fertility.

BadRising FSH on day 3 signals approaching menopause and declining ovarian reserve. Sustained high FSH confirms menopause.

What it isA pituitary hormone that surges mid-cycle to trigger ovulation. Outside the surge, it sits at lower baseline levels.

DoesDrives ovulation and stimulates ovarian theca cells to produce androgens, which then aromatize to estradiol.

GoodCycle-appropriate baseline LH with a clean mid-cycle surge signals normal ovulatory.

BadPersistently elevated LH with an LH:FSH ratio above 2 is a hallmark of PCOS. High LH at menopause is expected.

What it isAMH is produced by small growing follicles in the ovary. Its level reflects the size of the pool of eggs still available — the ovarian reserve.

DoesProvides the most reliable single-snapshot estimate of remaining fertility potential and time to menopause.

GoodAge-appropriate AMH signals adequate ovarian reserve and supports reproductive planning.

BadLow AMH for age signals diminished ovarian reserve and predicts earlier menopause and shorter window for biological children. Very high AMH suggests PCOS.

What it isA steroid intermediate in the pathway from cholesterol to cortisol and androgens. Adrenals and ovaries both produce it.

DoesActs as a marker of adrenal steroid biosynthesis and a screening tool for enzyme deficiencies.

GoodCycle-appropriate 17-OHP signals normal adrenal and ovarian steroid biosynthesis.

BadElevated 17-OHP suggests congenital adrenal hyperplasia (especially non-classical 21-hydroxylase deficiency) or PCOS.

What it isA pituitary hormone primarily known for driving milk production but with broader roles in reproduction, immunity, and mood.

DoesStimulates milk production and suppresses ovulation by inhibiting GnRH.

GoodMid-range prolactin signals an unobstructed reproductive axis.

BadElevated prolactin suppresses ovulation, causing amenorrhea, infertility, and sometimes galactorrhea. Very high levels suggest a pituitary tumor (prolactinoma).

What it isA composite measurement that sums estrone, estradiol, and estriol into one number.

DoesCaptures overall estrogenic exposure when individual estrogen fractions don't tell the full story.

GoodCycle-appropriate or HRT-appropriate levels signal balanced estrogen exposure.

BadPersistently elevated total estrogens can drive endometrial hyperplasia and breast cancer risk.

What it isPTH is the master regulator of calcium balance, released by the four parathyroid glands when blood calcium falls.

DoesRaises blood calcium by pulling calcium from bone, activating vitamin D in the kidney to enhance gut absorption, and decreasing kidney calcium excretion.

GoodA mid-range PTH with optimal vitamin D and calcium signals balanced mineral homeostasis.

BadHigh PTH with high calcium signals primary hyperparathyroidism (often a benign adenoma) that drives bone loss, kidney stones, and cognitive symptoms. High PTH with low/normal calcium reflects vitamin D deficiency. Low PTH is rare.

What it isOsteocalcin is a small protein made by osteoblasts (bone-building cells) and released into circulation during bone formation. It also functions as a hormone influencing glucose metabolism and male reproductive.

DoesMarks new bone formation; binds calcium and helps incorporate it into bone matrix; signals to pancreas and other tissues.

GoodMid-range osteocalcin signals active bone formation and healthy skeletal remodeling.

BadLow osteocalcin suggests reduced bone formation and may track diabetes and metabolic dysfunction. High osteocalcin reflects accelerated turnover.

What it isCTX is a fragment of type 1 collagen released into blood when osteoclasts (bone-resorbing cells) break down bone matrix.

DoesReports the rate of bone resorption.

GoodMid-range CTX with adequate bone formation markers signals balanced remodeling.

BadHigh CTX signals accelerated bone loss in osteoporosis. Low CTX confirms response to bisphosphonate therapy but if suppressed too low may track atypical fracture risk.

What it isP1NP is a fragment released when osteoblasts make new type 1 collagen — the dominant protein in bone.

DoesMarks the pace of bone formation.

GoodMid-range P1NP signals active bone formation.

BadLow P1NP signals reduced bone building. P1NP monitoring guides anabolic osteoporosis therapy.

What it isA liver-made carrier protein that binds vitamin D metabolites in circulation, parallel to how SHBG binds sex hormones.

DoesBuffers vitamin D availability to tissues.

GoodA mid-range DBP allows free and bound vitamin D to coexist in healthy balance.

BadGenetic variation in DBP affects bioavailable vitamin D and explains why some people benefit from vitamin D supplementation more than others.

What it is25-hydroxyvitamin D is the storage form of vitamin D circulating in blood. It's produced in skin from sunlight, absorbed from a few foods and supplements, and converted in the liver from inactive vitamin D.

DoesServes as the substrate the kidneys convert to active calcitriol; also acts directly on immune cells, neurons, and other tissues.

GoodAdequate 25-OH vitamin D supports bone density, immune balance, mood, cardiovascular health, and may reduce cancer risk.

BadLow 25-OH vitamin D drives osteoporosis, depressed mood, immune dysregulation, autoimmunity, and may increase risk of cardiovascular disease and several cancers.

What it isCalcitriol is the active hormonal form of vitamin D, produced by the kidneys from 25-OH vitamin D. It binds the vitamin D receptor and drives gene expression.

DoesRegulates calcium absorption from the gut, modulates immune, and influences hundreds of genes.

GoodA mid-range calcitriol with appropriate 25-OH vitamin D signals balanced vitamin D physiology.

BadCalcitriol can be normal or high even when 25-OH vitamin D is low — making it a poor screening test. It rises pathologically in granulomatous disease (sarcoidosis, tuberculosis) and some lymphomas.

What it isB12 is a cobalt-containing vitamin made by bacteria and obtained almost exclusively from animal foods. It requires intrinsic factor from the stomach for absorption in the ileum.

DoesActs as a cofactor in DNA synthesis, red blood cell production, fatty acid metabolism, and myelin formation around nerves.

GoodHigh-normal B12 supports red cell production, methylation, mood, and cognitive.

BadLow B12 causes megaloblastic anemia, peripheral neuropathy, cognitive impairment that mimics dementia, and elevated homocysteine. Common in vegans, older adults, and those on metformin or acid-suppressing drugs.

What it isMethylmalonic acid is a metabolite that accumulates when B12 is functionally deficient inside cells, regardless of serum B12 levels.

DoesProvides the gold-standard functional marker of cellular B12 status.

GoodLow MMA confirms adequate cellular B12 even when serum B12 looks borderline.

BadElevated MMA reveals true cellular B12 deficiency, often missed by serum B12 alone, and predicts neuropathy and cognitive issues.

What it isFolate is a B vitamin essential for DNA synthesis, red blood cell production, and the methylation cycle. Serum folate reflects recent intake.

DoesProvides single-carbon units used in DNA synthesis, amino acid metabolism, and the conversion of homocysteine back to methionine.

GoodHigh-normal folate supports methylation, red cell production, and cardiovascular health through homocysteine control.

BadLow folate causes megaloblastic anemia, elevated homocysteine, and in pregnancy, neural tube defects. Excess synthetic folic acid can mask B12 deficiency.

What it isFolate stored inside red blood cells. Because red cells live about 120 days, RBC folate reflects average folate status over the preceding several months.

DoesCaptures long-term folate status rather than the swings serum folate shows.

GoodHigh RBC folate confirms sustained adequate intake.

BadLow RBC folate signals chronic deficiency, even when serum folate looks acceptable.

What it isThiamine is a B vitamin essential for converting carbohydrates into energy. It exists in cells as thiamine pyrophosphate, a cofactor for several key metabolic enzymes.

DoesDrives carbohydrate metabolism, ATP production, and nerve conduction.

GoodAdequate thiamine supports energy production and neurological.

BadDeficiency causes wet beriberi (cardiomyopathy), dry beriberi (peripheral neuropathy), and Wernicke-Korsakoff syndrome. Common in alcohol use disorder, post-bariatric surgery, and high-glucose diets without adequate B vitamins.

What it isRiboflavin is a B vitamin that forms the cofactors FAD and FMN, central to mitochondrial energy production and antioxidant defense.

DoesDrives oxidative metabolism, supports glutathione recycling, and helps activate other B vitamins including B6 and folate.

GoodAdequate riboflavin supports mitochondrial energy and migraine prevention.

BadDeficiency causes cracks at mouth corners, glossitis, and contributes to migraine, particularly in those with mitochondrial vulnerability.

What it isPyridoxal-5-phosphate is the active form of vitamin B6, serving as a cofactor in over 150 enzymatic reactions including amino acid and neurotransmitter metabolism.

DoesDrives serotonin, dopamine, GABA, and norepinephrine synthesis; contributes to heme production; supports homocysteine clearance.

GoodAdequate B6 supports neurotransmitter balance, sleep, mood, and methylation.

BadLow B6 contributes to depression, PMS, peripheral neuropathy, and elevated homocysteine. Paradoxically, very high doses of B6 over time can also cause neuropathy.

What it isRetinol is the preformed, active form of vitamin A, found in animal foods. The body also converts plant carotenoids (especially beta-carotene) to retinol, though inefficiently.

DoesDrives vision, epithelial cell turnover, immune, sperm production, and fetal development.

GoodAdequate retinol supports skin, vision, immune, and reproductive health.

BadDeficiency causes night blindness, impaired immunity, and skin problems. Excess (typically from chronic high-dose supplementation, not diet) causes hepatotoxicity, bone loss, and is teratogenic.

What it isVitamin C is a water-soluble antioxidant that humans cannot synthesize — it must come from food. It accumulates in immune cells, brain, and the adrenal glands.

DoesDonates electrons to neutralize reactive oxygen species, drives collagen synthesis, regenerates vitamin E, supports immune, and aids iron absorption.

GoodAdequate vitamin C supports skin, immune, vascular health, and antioxidant capacity.

BadDeficiency causes scurvy — bleeding gums, poor wound healing, anemia. Subclinical insufficiency tracks with cardiovascular and immune issues.

What it isVitamin E is a family of fat-soluble antioxidants. Alpha-tocopherol is the most active form in humans, but the mixed tocopherols and tocotrienols together provide the full benefit.

DoesProtects cell membrane lipids from peroxidation; supports cardiovascular and neurological health.

GoodAdequate vitamin E protects membranes against oxidative damage and supports skin and cardiovascular health.

BadDeficiency is rare in adults but causes neuropathy and anemia. High-dose alpha-tocopherol alone can disrupt the mixed tocopherol balance and raise bleeding risk.

What it isVitamin K1 is the plant-derived form of vitamin K, abundant in leafy greens. The liver uses it primarily to activate clotting factors.

DoesDrives the activation of clotting factors II, VII, IX, and X.

GoodAdequate K1 supports normal clotting and is easily obtained through diet.

BadDeficiency causes bleeding tendencies. Rare in adults eating any greens; relevant for newborns.

What it isVitamin K2 is the bacterially-produced form of vitamin K, found in fermented foods and animal products. MK-4 is short-acting; MK-7 has a much longer half-life.

DoesActivates osteocalcin (which directs calcium into bone) and matrix Gla protein (which keeps calcium out of soft tissues including arteries).

GoodAdequate K2 directs calcium where it belongs and may reduce arterial calcification.

BadInadequate K2 contributes to soft-tissue calcification and bone fragility. Direct measurement is uncommon; undercarboxylated osteocalcin serves as a functional marker.

What it isBiotin is a B vitamin that serves as a cofactor for carboxylase enzymes involved in fatty acid synthesis and amino acid metabolism.

DoesSupports keratin production (hair, skin, nails) and metabolic enzyme.

GoodAdequate biotin supports skin, hair, and nail health.

BadDeficiency is rare but causes hair loss, brittle nails, and rashes. High-dose biotin supplementation interferes with many immunoassays — including thyroid, troponin, and hormone tests — and can produce dangerously misleading results.

What it isCarotenoids are a family of plant pigments — beta-carotene, alpha-carotene, lycopene, lutein, zeaxanthin — that the body partially converts to vitamin A and uses as antioxidants.

DoesProvide antioxidant protection in plasma and tissues; support eye, skin, and immune health; some converts to vitamin A.

GoodMid-high carotenoid levels reflect a colorful plant-rich diet and predict lower cardiovascular and cancer mortality.

BadLow carotenoids suggest a low plant intake. Very high beta-carotene from supplementation in smokers paradoxically increases lung cancer risk.

What it isCoQ10 is a fat-soluble compound found in mitochondrial membranes throughout the body. The body synthesizes it through the mevalonate pathway — the same pathway statins inhibit.

DoesShuttles electrons in the mitochondrial electron transport chain to make ATP and serves as a potent membrane antioxidant.

GoodAdequate CoQ10 supports energy production, cardiac, and antioxidant defense.

BadLow CoQ10 contributes to fatigue, muscle pain, and cardiovascular issues. Statins suppress CoQ10 synthesis. Levels decline with age.

What it isSodium is the principal positively charged ion in extracellular fluid. The kidneys, working under the direction of aldosterone, ADH, and the brain's thirst centers, defend its concentration within tight limits.

DoesSets extracellular osmolality, drives fluid balance, supports nerve impulse transmission and muscle contraction.

GoodMid-range sodium signals balanced hydration and intact hormonal regulation.

BadLow sodium (hyponatremia) reflects water excess relative to sodium and can cause confusion, seizures, and death if severe. High sodium reflects water deficit, common with dehydration in older adults.

What it isPotassium is the primary positively charged ion inside cells. The body maintains a steep gradient — high inside, low outside — that powers nearly every electrical signal in the body.

DoesSets cell membrane resting potential, drives nerve and muscle (including cardiac), regulates blood pressure.

GoodMid-range potassium supports stable cardiac rhythm and normal nerve and muscle.

BadLow potassium (hypokalemia) causes muscle weakness, cramps, and dangerous arrhythmias. High potassium (hyperkalemia) can stop the heart.

What it isChloride is the principal negatively charged ion in extracellular fluid, paired with sodium in salt.

DoesMaintains charge balance with sodium, supports acid-base balance, and is essential for stomach acid (HCl) production.

GoodMid-range chloride signals balanced electrolyte and acid-base status.

BadLow chloride accompanies vomiting and metabolic alkalosis. High chloride accompanies dehydration or metabolic acidosis.

What it isBicarbonate is the body's main extracellular buffer. The kidneys regulate it to maintain blood pH within a tight range.

DoesNeutralizes metabolic acids; works with the lungs to maintain acid-base balance.

GoodMid-range bicarbonate signals balanced acid-base physiology.

BadLow bicarbonate indicates metabolic acidosis — chronic kidney disease, diabetic ketoacidosis, lactic acidosis. High bicarbonate indicates metabolic alkalosis from vomiting, diuretics, or chronic respiratory compensation.

What it isTotal blood calcium is the sum of free (ionized) calcium and calcium bound to albumin and other proteins. Most body calcium is stored in bone; the small fraction in blood is tightly regulated.

DoesDrives nerve and muscle excitability, blood clotting, and intracellular signaling.

GoodMid-range calcium reflects intact parathyroid and vitamin D physiology and adequate bone mineral homeostasis.

BadHigh calcium suggests hyperparathyroidism, malignancy, or vitamin D toxicity. Low calcium suggests vitamin D deficiency, hypoparathyroidism, or kidney disease.

What it isA calculation that adjusts total calcium for albumin level. Since most calcium binds to albumin, low albumin reduces total calcium even when the active ionized fraction is normal.

DoesProvides a more accurate estimate of calcium status when albumin is abnormal.

GoodMid-range corrected calcium signals truly intact calcium homeostasis.

BadSame patterns as total calcium, but with confounding from low albumin removed.

What it isThe free, unbound fraction of blood calcium that is biologically active at receptors.

DoesDrives all physiological calcium effects — nerve, muscle, clotting, signaling.

GoodMid-range ionized calcium signals true calcium adequacy regardless of albumin status.

BadProvides the most accurate calcium status, particularly when parathyroid disease is suspected or in critically ill patients with abnormal albumin.

What it isMagnesium is a divalent cation that serves as a cofactor in over 300 enzyme reactions. Only about 1% of body magnesium is in blood; most is in bone and inside cells.

DoesDrives ATP-dependent reactions, stabilizes nerve and muscle membranes, modulates calcium and potassium channels, supports DNA synthesis and insulin signaling.

GoodMid-range serum magnesium signals adequate magnesium status, though serum is a poor reflection of total body stores.

BadEven high-normal serum magnesium can mask intracellular deficiency. True magnesium deficiency drives muscle cramps, arrhythmias, insulin resistance, migraine, anxiety, and insomnia.

What it isMagnesium measured inside red blood cells, providing a window on intracellular magnesium status that serum can't show.

DoesReports true cellular magnesium availability where most of magnesium's biology happens.

GoodMid-high RBC magnesium signals adequate cellular magnesium stores.

BadLow RBC magnesium reveals deficiency hidden by normal serum magnesium and explains symptoms (cramps, palpitations, insomnia, anxiety) in those whose serum looks fine.

What it isPhosphorus circulates mostly as phosphate. The body uses it in bone mineralization, in ATP, in DNA, and in cell membranes.

DoesCo-mineralizes bone with calcium, powers ATP-based energy transfer, structures DNA, and supports membrane phospholipids.

GoodMid-range phosphate signals balanced kidney and parathyroid and adequate bone mineral handling.

BadHigh phosphate in chronic kidney disease drives vascular calcification and predicts cardiovascular mortality. Low phosphate is rare but causes muscle weakness and bone pain.

What it isZinc is a trace mineral and the second most abundant trace metal in the body. It serves as a structural and catalytic cofactor for thousands of proteins.

DoesDrives immune, taste, wound healing, testosterone synthesis, DNA repair, and antioxidant defense.

GoodMid-high zinc supports immune resilience, androgen synthesis, skin health, and gut barrier.

BadDeficiency causes impaired immunity, poor wound healing, low testosterone, loss of taste and smell, and increased infection susceptibility. Common in older adults, vegetarians, and on proton pump inhibitors.

What it isCopper is a trace mineral essential for iron metabolism, energy production, and connective tissue. It travels in blood mostly bound to ceruloplasmin.

DoesDrives oxidative metabolism, iron mobilization, collagen and elastin cross-linking, and brain neurotransmitter synthesis.

GoodMid-range copper with balanced zinc supports iron metabolism, tissue integrity, and neurotransmitter.

BadHigh copper relative to zinc is pro-inflammatory and tracks anxiety and oxidative stress. Low copper causes anemia, neuropathy, and reduced immune. Common with high-dose zinc supplementation or after bariatric surgery.

What it isA ratio of zinc to copper that captures the balance between two minerals with opposing inflammatory effects.

DoesIndexes inflammatory tone and oxidative balance through these two trace mineral cofactors.

GoodA balanced ratio supports immune, mood, and oxidative balance.

BadLow ratio (high copper relative to zinc) tracks chronic inflammation, anxiety, ADHD, and oxidative stress. High ratio risks copper deficiency.

What it isSelenium is a trace mineral incorporated into selenoproteins, including glutathione peroxidase and the deiodinases that convert T4 to T3.

DoesPowers the body's master antioxidant glutathione system, drives thyroid hormone activation, and supports immune.

GoodMid-high selenium supports thyroid conversion, antioxidant defense, and immune resilience.

BadLow selenium impairs T4-to-T3 conversion, weakens antioxidant defense, and increases autoimmune thyroid risk. Excess causes selenosis — hair loss, brittle nails, neurological symptoms.

What it isIodine is a halogen the thyroid uses to build T4 and T3. The body has no other meaningful use for it.

DoesProvides the essential building block of thyroid hormone.

GoodMid-range iodine supports thyroid hormone synthesis.

BadDeficiency causes goiter and hypothyroidism. Excess iodine — particularly in those with autoimmune thyroid disease — can trigger or worsen Hashimoto's.

What it isManganese is a trace mineral cofactor for antioxidant and bone-forming enzymes, including mitochondrial superoxide dismutase.

DoesDrives bone mineralization, mitochondrial antioxidant defense, and connective tissue synthesis.

GoodMid-range manganese supports bone and antioxidant.

BadDeficiency is rare. Excess from environmental or occupational exposure is neurotoxic and causes parkinsonian symptoms.

What it isChromium is a trace mineral that historically was thought to enhance insulin sensitivity. Its role as an essential nutrient is now debated.

DoesMay enhance insulin receptor sensitivity, though evidence is modest.

GoodMid-range chromium signals adequate intake.

BadFrank deficiency rarely identified; supplementation effects on glucose modest.

What it isBoron is an ultratrace mineral with emerging roles in hormone metabolism and bone health.

DoesModestly raises testosterone and free testosterone by lowering SHBG, supports bone mineral density, and may reduce inflammation.

GoodAdequate boron may support bone, hormone balance, and joint health.

BadFrank deficiency not well-defined; excess is rare from food.

What it isA calculation that subtracts the major measured anions (chloride and bicarbonate) from the major measured cations (sodium and sometimes potassium). The difference represents unmeasured anions like lactate, ketones, and phosphates.

DoesIdentifies metabolic acidosis from accumulation of organic acids.

GoodA normal anion gap signals balanced acid-base status.

BadA wide anion gap signals lactic acidosis, ketoacidosis, kidney failure, or toxic ingestions — generally an emergency.

What it isA screening test for antibodies that target the cell nucleus. ANA appears in lupus and many other systemic autoimmune diseases.

DoesActs as the first-pass screen for systemic autoimmune disease.

GoodA negative ANA effectively rules out most systemic autoimmune disease.

BadA positive ANA, especially at high titers and with characteristic patterns, prompts evaluation for lupus, scleroderma, mixed connective tissue disease, Sjögren's, or autoimmune hepatitis. Low-titer positives occur in healthy people.

What it isAn autoantibody, usually IgM class, that targets the Fc portion of IgG antibodies.

DoesActs as a traditional rheumatoid arthritis marker; also rises in some chronic infections.

GoodA negative RF makes rheumatoid arthritis less likely but doesn't rule it out (seronegative RA exists).

BadPositive RF supports rheumatoid arthritis diagnosis but isn't specific — chronic hepatitis C, Sjögren's, and other conditions also trigger it.

What it isAnti-citrullinated protein antibodies target proteins that have undergone citrullination — a post-translational modification.

DoesMarks rheumatoid arthritis with high specificity.

GoodA negative anti-CCP largely rules out rheumatoid arthritis.

BadPositive anti-CCP confirms rheumatoid arthritis, often before clinical disease appears, and predicts more aggressive disease and joint erosion.

What it isAutoantibodies that target double-stranded DNA, found primarily in systemic lupus erythematosus.

DoesMarks lupus with high specificity and correlates with disease activity, particularly kidney involvement.

GoodNegative anti-dsDNA in someone with positive ANA argues against active SLE.

BadElevated anti-dsDNA confirms lupus and rising titers predict flares, especially renal involvement.

What it isAutoantibodies that target Smith nuclear ribonucleoprotein, one of the most specific markers for systemic lupus.

DoesConfirms lupus diagnosis when positive.

GoodNegative excludes one specific lupus marker but doesn't rule out the disease.

BadPositive anti-Sm is highly specific for lupus and supports diagnosis even when ANA pattern is ambiguous.

What it isAutoantibodies that target the Ro and La ribonucleoprotein particles. They appear in Sjögren's syndrome and lupus.

DoesMark Sjögren's syndrome (dry eyes and mouth from autoimmune exocrine gland attack) and lupus subsets.

GoodNegative results argue against Sjögren's in someone with sicca symptoms.

BadPositive results confirm Sjögren's syndrome or, in pregnancy, predict risk of congenital heart block in the fetus.

What it isAutoantibodies targeting centromere proteins during cell division. Highly associated with limited systemic sclerosis (CREST syndrome).

DoesMarks limited cutaneous systemic sclerosis.

GoodNegative result in someone with Raynaud's or skin tightening argues against limited scleroderma.

BadPositive anti-centromere identifies limited scleroderma and predicts pulmonary hypertension as a major complication.

What it isAutoantibodies targeting topoisomerase I (Scl-70), associated with diffuse cutaneous systemic sclerosis.

DoesMarks the diffuse, more aggressive form of systemic sclerosis.

GoodNegative result in someone with skin changes argues against diffuse scleroderma.

BadPositive anti-Scl-70 identifies diffuse scleroderma and predicts interstitial lung disease and progressive internal organ involvement.

What it isAutoantibodies targeting tissue transglutaminase, the enzyme that modifies gluten peptides in the gut. tTG-IgA is the primary blood screen for celiac disease.

DoesMarks active celiac disease in someone consuming gluten.

GoodNegative tTG-IgA in someone consuming gluten effectively rules out celiac disease (assuming IgA isn't deficient).

BadPositive tTG-IgA strongly suggests celiac disease and prompts biopsy confirmation; remains positive while celiac is untreated.

What it isIgA antibodies targeting endomysium, the connective tissue around muscle fibers. Highly specific for celiac disease.

DoesConfirms celiac when tTG-IgA is ambiguous.

GoodNegative result alongside negative tTG-IgA effectively rules out celiac.

BadPositive EMA is nearly 100% specific for celiac disease.

What it isAntibodies (IgA or IgG) targeting deamidated gliadin, a fragment of gluten that has been chemically modified by tissue transglutaminase.

DoesDetects celiac disease, particularly useful in IgA-deficient patients where tTG-IgA can give false negatives.

GoodNegative result alongside other celiac markers argues against the disease.

BadPositive DGP-IgG is especially valuable in IgA deficiency and in young children.

What it isAutoantibodies targeting the parietal cells of the stomach lining, which produce acid and intrinsic factor needed for B12 absorption.

DoesMarks autoimmune atrophic gastritis, which destroys parietal cells over time.

GoodNegative result argues against autoimmune gastritis.

BadPositive APCA flags autoimmune gastritis, which leads to B12 deficiency, iron deficiency, and increased gastric cancer risk over decades.

What it isAutoantibodies that block intrinsic factor — the stomach-made protein required for B12 absorption in the ileum.

DoesCauses pernicious anemia by preventing B12 absorption regardless of dietary intake.

GoodNegative result rules out classical pernicious anemia.

BadPositive anti-intrinsic factor confirms pernicious anemia and indicates lifelong B12 supplementation or injections are needed.

What it isThe major classes of antibodies produced by B cells and plasma cells. Each class plays a distinct immune role.

DoesIgG provides long-term immunity and crosses the placenta; IgA defends mucosal surfaces; IgM is the first responder to new antigens; IgE drives allergic reactions and antiparasite immunity.

GoodMid-range immunoglobulins signal balanced humoral immunity.

BadLow immunoglobulins flag immunodeficiency and increase infection risk. High IgE indicates allergy or parasitic infection. Monoclonal spikes suggest plasma cell disorders.

What it isIgG comes in four subclasses (IgG1, 2, 3, 4) that differ in. IgG1 and IgG3 fight viruses; IgG2 fights encapsulated bacteria; IgG4 modulates allergic responses.

DoesProvides nuanced view of humoral immunity beyond total IgG.

GoodBalanced subclass distribution signals robust humoral immunity.

BadSelective subclass deficiency (especially IgG2 or IgG3) can cause recurrent infections despite normal total IgG. Elevated IgG4 marks IgG4-related disease.

What it isThe antibody class that mediates allergic responses and parasite defense. Produced by plasma cells, IgE binds to mast cells and basophils where allergen cross-linking triggers histamine release. Total IgE reflects overall allergic and parasitic burden.

DoesDrives immediate hypersensitivity reactions; defends against helminth parasites.

GoodLow total IgE reflects minimal atopic burden and reduced risk of asthma, eczema, and allergic disease.

BadElevated IgE correlates with atopic disease (asthma, eczema, allergic rhinitis), parasitic infection, certain immunodeficiencies (hyper-IgE syndrome), and some malignancies. Very high levels point to systemic atopy or parasite load.

What it isBlood tests measuring IgE antibodies against specific allergens — pollens, danders, foods, molds, venoms. They confirm sensitization but not clinical allergy, which requires a corresponding reaction history.

DoesIdentifies the specific allergens to which someone has produced IgE; guides avoidance and immunotherapy decisions.

GoodNegative results across a panel reduce the case for hidden allergen-driven symptoms.

BadPositive specific IgE in someone with consistent symptoms identifies the trigger. Positive results without symptoms indicate asymptomatic sensitization that may or may not become clinically relevant; over-restriction based on sensitization alone causes nutritional and quality-of-life harm.

What it isA protease stored in mast cell granules and released during degranulation. Baseline tryptase reflects total mast cell burden; acute tryptase rises sharply during anaphylaxis and returns to baseline within hours.

DoesMarker for mast cell activation and total mast cell number; key in diagnosing anaphylaxis, mast cell activation syndrome, and mastocytosis.

GoodA low, stable baseline tryptase reflects normal mast cell burden and argues against systemic mastocytosis.

BadPersistently elevated baseline tryptase above 20 ng/mL raises concern for systemic mastocytosis. Acute elevation supports a diagnosis of anaphylaxis when measured during a reaction. Hereditary alpha-tryptasemia causes lifelong baseline elevation with variable symptoms.

What it isTwo central proteins of the complement cascade, an ancient arm of the immune system that opsonizes pathogens and triggers inflammation. Both are produced by the liver and behave as acute-phase reactants, rising with inflammation and consumed during active immune-complex disease.

DoesC3 and C4 levels track complement consumption in immune complex-mediated disease and overall inflammatory activity.

GoodMid-normal C3 and C4 reflect intact complement without active immune-complex disease.

BadLow levels suggest active autoimmune disease (lupus flare, immune complex glomerulonephritis, cryoglobulinemia, hereditary angioedema for C4). Persistently high levels reflect chronic inflammation or acute-phase response.

What it isA surface protein of the hepatitis B virus that appears in blood during active infection — either acute or chronic.

DoesIdentifies current hepatitis B infection.

GoodNegative HBsAg signals no active hepatitis B infection.

BadPositive HBsAg confirms active hepatitis B infection, which can be acute or chronic, and risks long-term progression to cirrhosis and liver cancer if chronic.

What it isAn antibody against the hepatitis B surface antigen, produced after vaccination or after recovery from infection.

DoesConfirms immunity to hepatitis B.

GoodA protective antibody level confirms immunity from vaccine or natural recovery.

BadLevels below the protective threshold suggest waning immunity and may prompt revaccination.

What it isAn antibody against the hepatitis B core antigen, produced only after actual infection — not after vaccination.

DoesDistinguishes vaccine-induced immunity (anti-HBs positive, anti-HBc negative) from past infection (both positive).

GoodNegative anti-HBc in someone with positive anti-HBs confirms vaccine immunity.

BadPositive anti-HBc with negative surface antigen usually indicates resolved past infection but can occasionally reactivate during immunosuppression.

What it isAn antibody to hepatitis C virus that appears within weeks of exposure and persists indefinitely after recovery or successful treatment.

DoesScreens for past or current hepatitis C infection.

GoodA negative anti-HCV rules out hepatitis C exposure.

BadPositive anti-HCV prompts confirmatory HCV RNA testing to distinguish active infection (treatable, curable) from resolved past infection.

What it isAn antibody indicating immunity to hepatitis A, either from vaccination or past infection.

DoesConfirms protection against hepatitis A.

GoodPositive result confirms immunity.

BadNegative result indicates susceptibility — vaccination recommended for travelers and those in food-handling occupations.

What it isA combined test that detects both the HIV p24 viral protein (which appears within 2–4 weeks of infection) and antibodies against HIV (which appear within weeks to months).

DoesScreens for HIV infection at high sensitivity with relatively short window.

GoodA negative test in someone past the window period effectively rules out HIV.

BadPositive results trigger confirmatory testing. Modern antiretroviral therapy makes HIV a manageable chronic condition with normal life expectancy.

What it isA nontreponemal antibody test that screens for syphilis. Positive results require confirmatory treponemal testing.

DoesDetects antibodies produced in response to syphilis infection.

GoodNonreactive result rules out current syphilis.

BadReactive results trigger confirmatory testing and treatment if active syphilis is confirmed. Untreated syphilis progresses through stages with serious neurological and cardiovascular complications.

What it isAntibodies against Borrelia burgdorferi, the bacterium transmitted by ticks that causes Lyme disease.

DoesConfirms past or active Lyme infection in someone with appropriate exposure and symptoms.

GoodNegative result in someone with symptoms argues against Lyme disease as the cause.

BadPositive results in the right clinical context confirm Lyme. Two-step testing (ELISA then Western blot) is the standard approach.

What it isA panel of antibodies against Epstein-Barr virus, the ubiquitous herpesvirus that causes mononucleosis and persists lifelong after primary infection. VCA-IgM marks acute infection, VCA-IgG marks past or current infection, EBNA-IgG marks remote past infection.

DoesDistinguishes acute from past EBV infection and helps investigate suspected reactivation in unexplained fatigue or lymphadenopathy.

GoodA pattern of EBNA-IgG positive with negative VCA-IgM indicates resolved past infection — the expected state in most adults.

BadActive VCA-IgM positivity confirms recent or current acute infection. Persistently elevated early antigen antibodies may reflect chronic active EBV, which is rare but linked to certain lymphoid cancers and post-viral syndromes.

What it isCytomegalovirus is a common herpesvirus that establishes lifelong latency after primary infection. Serology detects antibodies indicating past exposure (IgG) or acute infection (IgM).

DoesEstablishes CMV exposure status, which matters before transplantation, in pregnancy, and in immunocompromised states where reactivation can be devastating.

GoodA clear IgG-positive, IgM-negative pattern indicates immune memory from resolved past infection — the usual state in adults.

BadActive IgM positivity confirms acute or recently reactivated infection. CMV reactivation in immunocompromised hosts drives retinitis, colitis, pneumonitis, and graft loss. Congenital CMV is a leading cause of hearing loss and developmental disability.

What it isA spiral bacterium that colonizes the stomach lining, often acquired in childhood and persisting silently for decades. Detected by stool antigen, urea breath test, or biopsy; antibody testing remains positive after eradication and is less useful for active infection.

DoesDrives chronic gastritis and is the leading infectious cause of peptic ulcer disease and gastric adenocarcinoma.

GoodA negative stool antigen or breath test in someone with dyspepsia rules out H. pylori as the cause and avoids unnecessary antibiotics.

BadActive infection causes gastritis, peptic ulcers, iron deficiency, B12 deficiency, and over decades raises gastric cancer and MALT lymphoma risk. Untreated infection is a known carcinogen.

What it isPSA is an enzyme produced almost exclusively by prostate epithelial cells. Small amounts leak into the bloodstream normally; more leaks when the prostate is inflamed, enlarged, or harbors malignancy.

DoesLiquefies semen physiologically and serves as the primary blood-based marker for prostate cancer screening and surveillance.

GoodA low, stable PSA tracks the absence of clinically significant prostate cancer and reassures across years of surveillance.

BadRising or elevated PSA flags benign prostatic hyperplasia, prostatitis, or prostate cancer. Velocity (rate of change) and density (PSA per gland volume) add specificity beyond the single number.

What it isA glycoprotein shed by ovarian and other epithelial cells, particularly when those cells are malignant or inflamed.

DoesActs primarily as a monitoring tool for ovarian cancer treatment response; not a reliable screening test.

GoodA low CA 125 in someone with known ovarian cancer signals treatment response or disease control.

BadElevated CA 125 has many causes — ovarian cancer, endometriosis, pelvic inflammatory disease, menstruation, pregnancy, ascites — making it poor for screening but useful for monitoring.

What it isA carbohydrate antigen shed by pancreatic, biliary, and some gastrointestinal cancers.

DoesMonitors pancreatic and biliary cancer treatment response and recurrence; not for screening.

GoodA low CA 19-9 in a patient with treated pancreatic cancer signals disease control.

BadElevated CA 19-9 can indicate pancreatic or biliary malignancy but also rises in benign biliary obstruction, pancreatitis, and cirrhosis. Some people lack the enzyme to produce it and run falsely low.

What it isA glycoprotein shed by breast cancer cells, particularly metastatic disease.

DoesMonitors treated breast cancer for recurrence; not a screening test.

GoodLow CA 15-3 in someone with treated breast cancer signals disease control.

BadRising CA 15-3 in treated breast cancer flags recurrence; also rises in benign breast and liver conditions.

What it isA protein produced during fetal development that some cancers — particularly colorectal — re-express in adulthood.

DoesMonitors treated colorectal cancer for recurrence; not a screening test.

GoodLow CEA in someone with treated colorectal cancer signals disease control.

BadRising CEA in treated colorectal cancer flags recurrence; also rises in smokers, IBD, and benign liver conditions.

What it isAFP is a fetal protein normally present in pregnancy. In adults, it rises with hepatocellular carcinoma and certain germ cell tumors.

DoesScreens for liver cancer in high-risk patients (cirrhosis, chronic hepatitis B/C) and monitors germ cell tumor treatment.

GoodLow AFP in a cirrhotic patient supports surveillance reassurance.

BadRising AFP in chronic liver disease flags possible hepatocellular carcinoma; elevation in young men can signal testicular germ cell tumor.

What it isA small protein found on the surface of nearly all nucleated cells, shed into blood at a steady rate proportional to cell turnover.

DoesActs as a prognostic marker in multiple myeloma and other lymphoid cancers; also reflects kidney.

GoodA low beta-2 microglobulin in a treated myeloma patient signals disease control.

BadElevated beta-2 microglobulin in myeloma predicts worse prognosis. Also rises with chronic inflammation and kidney impairment.

What it isA blood test that analyzes methylation patterns on cell-free DNA fragments to look for signals from over 50 cancer types, including many without traditional screening tests.

DoesCasts a wide net for early cancer signal across multiple organ systems.

GoodNo signal detected provides reassurance, though it does not substitute for routine screening tests.

BadA positive cancer signal triggers a directed diagnostic workup. False positives and false negatives both occur, particularly for early-stage cancers.

What it isA hormone produced by C cells of the thyroid gland that helps regulate calcium homeostasis.

DoesLowers blood calcium by inhibiting bone resorption; serves as the tumor marker for medullary thyroid cancer.

GoodLow calcitonin signals no medullary thyroid cancer.

BadElevated calcitonin suggests medullary thyroid carcinoma, particularly in those with a thyroid nodule or family history of MEN2.

What it isLight chains are the small subunits of antibodies. A small amount of free, unbound light chains circulates normally; cancers of plasma cells produce one type in vast excess.

DoesScreens for and monitors plasma cell disorders — multiple myeloma, MGUS, AL amyloidosis.

GoodBalanced kappa and lambda with a normal ratio rules out monoclonal plasma cell disease.

BadSkewed ratio with elevation of one light chain type strongly suggests plasma cell dyscrasia. Persistent imbalance prompts hematology evaluation.

What it isA toxic heavy metal with no known biological role. Lead enters the body through old paint, plumbing, contaminated water, leaded gasoline residue, certain spices and cookware, and some occupational sources. It stores in bone for decades and re-mobilizes during pregnancy, lactation, and bone loss.

DoesDisrupts enzymes that depend on zinc and calcium, impairs heme synthesis, damages neurons, and stiffens arteries.

GoodA near-undetectable lead level signals minimal cumulative exposure and protects cognition, blood pressure, and kidney over decades.

BadEven low chronic exposure raises blood pressure, accelerates kidney decline, lowers IQ in children, and increases cardiovascular mortality. There is no safe threshold — risk rises continuously from zero.

What it isA neurotoxic heavy metal. In adults, the dominant exposure is methylmercury from predator fish (tuna, swordfish, shark, king mackerel); elemental mercury exposure comes from dental amalgam and certain occupations. Methylmercury crosses the blood-brain and placental barriers.

DoesDisrupts neuronal, generates oxidative stress, impairs mitochondrial energetics, and crosses the placenta affecting fetal neurodevelopment.

GoodA low mercury level reflects modest exposure and protects neurological, cardiovascular health, and fetal development in pregnancy.

BadElevated levels cause tremor, paresthesias, cognitive slowing, mood disturbance, and in pregnancy impair fetal brain development. Subclinical elevation in heavy fish eaters is common and reversible by changing diet.

What it isA metalloid that exists in toxic inorganic forms (water, rice, some well water) and largely non-toxic organic forms (seafood). Speciation testing distinguishes the two; total arsenic alone overestimates risk in fish eaters.

DoesInorganic arsenic damages DNA, disrupts methylation, drives oxidative stress, and is a recognized human carcinogen.

GoodLow inorganic arsenic protects against skin, bladder, lung, and liver cancers and supports cardiovascular and cognitive health over decades.

BadChronic inorganic arsenic exposure raises cancer risk, drives peripheral vascular disease, and impairs glucose control. Acute high exposure causes gastrointestinal, neurological, and cardiac toxicity.

What it isA ubiquitous metal with no biological role. Exposure comes from antiperspirants, antacids, processed food additives, certain cookware, and historically from dialysis water. Healthy kidneys excrete it; chronic kidney disease impairs clearance.

DoesAt elevated levels, deposits in bone and brain where it interferes with neuronal and osteoblast.

GoodLow plasma aluminum protects bone, nervous system, and red blood cell formation, particularly in kidney disease.

BadAccumulated aluminum causes dialysis-associated dementia, osteomalacia, and microcytic anemia. Routine exposure in healthy people is not strongly linked to dementia despite popular concern, but high levels in dialysis or premature infants are clearly harmful.